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1 Introduction 
Over the last 200 years average life expectancy of humans has increased significantly. 
Especially since the beginning of the 20th century, it has increased from around 50 years 
to around 80-85 years in developed countries. Much of this dramatic rise in life 
expectancy can be ascribed to socio-economic developments as well as advancements 
in medical sciences which helped to conquer early and mid-life mortality during the first 
half of the 20th century. The further improvement in life expectancy was driven by a 
reduction in late-life mortality in the past 50 years (Christensen et al. 2006; Kirkwood 
2008) (Figure 1-1).  
 
 
Figure 1-1 Steady increase in life expectancy over the last 200 years. The graph depicts the life 
expectancy in the then longest-living country. During the 19th and early 20th century, the 
increase in life expectancy was due to decline in early and mid-life mortality, which was followed 
by decline in late-life mortality in the latter half of the 20th century (Source: Kirkwood 2008).   
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Due to the unprecedented increase in life expectancy during the past century, the 
population aged 80 and over is growing faster than any younger section of the older 
population. In 2000, the 80+ segment of the population were around 69 million, and by 
2050 people over 80 are projected to reach almost 379 million worldwide (i.e., 4.1% of 
the total human population) (Population division, DESA, United Nations). Since 
chronological age is the major risk factor for many diseases such as cardiovascular 
disease, type 2 diabetes, Alzheimer’s and cancer, this change in the age structure of the 
population will have major impacts on society, economy, health care and the social 
system (Christensen et al. 2009). Consequently, a primary focus should be to decipher 
what contributes to healthy ageing. One key element of this approach is to understand 
the underlying molecular mechanisms as presented in this study, which will help to 
extend the health span of the elderly and reduce the risk of disabilities and diseases.   
  
1.1 The phenotype of longevity 
Although age is the major risk factor for many age-related diseases, there is a subset of 
elderly who do not follow the disease paradigm. They live to the 95th percentile of their 
respective birth cohort and are classified as long-lived individuals (LLI) (Gudmundsson et 
al. 2000). A majority of such long-lived people have been healthy and independent for 
most of their lives and experience a relatively rapid terminal decline (Hitt et al. 1999). 
They seem to attain exceptional ages not because they age more slowly but because 
they postpone ageing and reach advanced age in a better state of health (Vaupel 2010). 
A study analyzing the health of supercentenarians (110-119 years), 
semisupercentenarians (105-109 years), centenarians (100-104 years), nonagenarians 
(87-99 years) and younger controls (47-86 years) observed that the older the age group, 
the later the onset of diseases such as cancer, cardiovascular disease, dementia, and 
stroke  as well as of cognitive and functional impairment (Andersen et al. 2012). The 
years spent with age-related diseases decrease with increasing age, which is a 
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phenomenon called compression of morbidity  (Andersen et al. 2012) (Figure 1-2). 
Furthermore, it was shown that the LLI fall into three morbidity profiles – survivors 
(onset of at least one age-related disease before age 80), delayers (onset of at least one 
age-related disease between 80 and 99 years of age) and escapers (onset of at least one 
age-related disease after age 100) – and that 87% of male and 83% of female subjects 
delayed or escaped age-related diseases (Evert et al. 2003). Additionally, the frequency 
of survivors decreases and the frequency of escapers increases with age (Andersen et al. 
2012) (Figure 1-3). Moreover, it has been observed that women live longer than men 
and make up a larger proportion of the older population. Although far fewer men reach 
the centenarian mark, they are usually healthier than their female counterparts 
(Franceschi et al. 2000b). Taken together, LLI represent a good model to study healthy 
longevity and to investigate key factors associated with it (Hitt et al. 1999; Franceschi 
and Bonafè 2003; Perls 2006; Engberg et al. 2009).  
  
            
Figure 1-2 Compression of morbidity.The boxplot depicts the percentage of life spent with 
disease in different age groups; Con=controls, Non=nonagenarians, Cen=centenarians, 
Sem=semisupercentenarians, Sup=supercentenarians (Source: Andersen et al. 2012).  
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Figure 1-3 Frequency of survivors, delayers and escapers among three age groups namely, 
centenarians (100-104 years), semisupercentenarians (105-109 years) and supercentenarians 
(110+ years) (Source: Andersen et al. 2012).  
 
1.2 Genetic epidemiology of human longevity 
Family-based studies have provided useful information on the influence of heritable 
factors, indicating that longevity is a complex phenotype partly influenced by genetic 
determinants. In 1934, a positive correlation was found between the lifespans of LLI (90 
years or older) and the lifespans of their parents and grandparents (Pearl 1934). In 1974, 
another study reported that children of long-lived parents tended to have long lifespan 
as well (Abbott et al. 1974). Furthermore, an increased relative probability of survival 
amongst siblings of nonagenarians (Westendorp et al. 2009) and of centenarians has 
been reported (Perls et al. 1998, 2002b; Willcox et al. 2006). In Iceland, first degree 
relatives of those living to the 95th percentile were  twice as likely to also live to the 95th 
percentile as compared to a control population (Gudmundsson et al. 2000). In addition, 
male and female siblings of centenarians were 17 times and 8 times more likely to 
become centenarians themselves compared with the controls, respectively (Perls et al. 
2002b). Besides an increased recurrence probability for surviving to extreme ages, the 
offspring of LLI have a lower prevalence of age-related diseases than age-matched 
controls (Terry et al. 2004; Westendorp et al. 2009). Additionally, they show beneficial 
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or youthful physiological characteristics for lipid and lipoprotein particle profiles, 
glucose metabolism and insulin sensitivity (Rozing et al. 2010; Slagboom et al. 2011; 
Deelen et al. 2013). All of these observations strongly argue that genetic factors play a 
significant role in attaining extreme ages. However, family-based studies cannot 
separate genetic effects from environmental effects based solely on phenotypic 
resemblance among family members. Twin studies, on the other hand, can distinguish 
between the two (Vogler 2001). 
 Longevity studies conducted on twins have consistently found that approximately 
20-30% of the variation in adult lifespan is accounted for by variation in genetic factors 
(McGue et al. 1993; Herskind et al. 1996; Ljungquist et al. 1998). Combined analyses 
using more than 20,000 Scandinavian twins showed that the genetic influences on 
lifespan are minimal prior to age 60 and only increase thereafter (vB Hjelmborg et al. 
2006), indicating that genetic variations, which have no impact in early life, are 
beneficial for older individuals. As the genetic influence on lifespan increases, it reaches 
approximately 40% in those individuals who survive beyond 85 years (Murabito et al. 
2012). These findings encouraged the ongoing search for genes that affect longevity in 
humans at advanced ages (vB Hjelmborg et al. 2006).   
  
1.3 Genetics of longevity 
1.3.1 Insights from model organisms 
Model organisms have significant similarity to humans with respect to genes, anatomy, 
and physiology (Danielle Simmons 2007). This similarity provided the opportunity to 
study longevity in model organisms such as Saccharomyces cerevisiae, Caenorhabditis 
elegans, Drosophila melanogaster and mice. Given their small size, short life span and 
the possibility to control environmental conditions and genotype, these model 
organisms are advantageous for studying genetic variants that are associated with 
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longevity (Christensen et al. 2006). Several studies in model organisms have provided 
significant insights into the type of genes that can influence lifespan. The first lifespan-
extending mutation was found in the C. elegans age-1 gene (Friedman and Johnson 
1988). The mean lifespan of the age-1 mutant was observed to be approximately 65% 
longer than that of the wild type (Friedman and Johnson 1988). Another significant 
lifespan-extending mutation was identified in the C. elegans daf-2 gene, and it was 
shown that daf-2 mutants live more than twice as long as the wild type (Kenyon et al. 
1993). Both of these genes have mammalian homologues: age-1 is homologous to the 
mammalian gene that encodes phosphatidylinositol-3-OH kinase catalytic subunits 
(PIK3C), which are positioned downstream of the insulin receptor (Morris et al. 1996), 
and daf-2 is homologous to the genes encoding the insulin receptor and insulin-like 
growth factor-1 (IGF-1) receptor (Kimura et al. 1997). These two genes act as key players 
in the insulin/ IGF-1 signalling (IIS) pathway (Figure 1-4), which was the first pathway 
shown to influence lifespan in C. elegans. The major target of this pathway is daf-16 that 
encodes the transcription factor DAF-16 (Forkhead box O (FOXO)), a protein that 
regulates the expression of other genes that mediate metabolic processes, stress 
resistance and antimicrobial response (Murphy et al. 2003). Reduced activity of DAF-2 
signalling not only causes an increase in lifespan, but also induces metabolic changes 
(Kimura et al. 1997). Similar to C. elegans, reduced activity of the IIS pathway extends 
lifespan also in other model organisms such as Drosophila (Tatar et al. 2001) and mice 
(Holzenberger et al. 2003). Taken together, this indicates that IIS is an evolutionarily 
conserved regulator of longevity.   
Another important pathway associated with lifespan extension is the target of 
rapamycin (TOR) pathway. TOR is a major amino acid and nutrient-sensing protein 
kinase that regulates growth and metabolism (Kapahi et al. 2010). Similar to the IIS 
pathway, reduced activity of the TOR pathway was shown to increase lifespan in C. 
elegans (Vellai et al. 2003), Drosophila (Kapahi et al. 2004), yeast (Kaeberlein et al. 2005) 
and mice (Harrison et al. 2009). 
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Figure 1-4 The IIS pathway found in C. elegans.The major components of the IIS pathway 
namely, daf-2, daf-16 and ins-7 have been found to regulate lifespan in C. elegans. Reduced 
activity of DAF-2 signalling, which induces lifespan extension in C. elegans, requires the activity 
of the transcription factor DAF-16. DAF-16 is known to inhibit expression of the DAF-2 agonist 
ins-7, and the reduced levels of INS-7 reduced DAF-2 activity which leads to lifespan extension 
(Source: Gems and McElwee 2003).   
 
Apart from IIS and TOR pathway genes, a number of other longevity genes have been 
identified in model organisms. The pathways and associated genes contributing to 
longevity are available in databases such as the NetAge (Tacutu et al. 2010) and GenAge 
(de Magalhaes and Toussaint 2004). 
Many genes that influence lifespan in model organisms have corresponding human 
homologues (Kuningas et al. 2008). The insights from model organisms have provided 
the motivation to elucidate whether similar longevity genes and mechanisms exist in 
humans.  
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1.3.2 Findings in humans 
Family-based studies and studies on model organisms support the notion that human 
longevity is also partially influenced by genetic factors. Although substantial progress 
has already been made in model organisms to unravel the genetic basis of longevity, 
thus far, variations in only two genes namely, apolipoprotein E (APOE) and forkhead box 
O3A gene (FOXO3A) have been found to be consistently associated with longevity in 
humans. Variants in APOE (Schächter et al. 1994; Zhang et al. 1998; Blanché et al. 2001; 
Christensen et al. 2006) and FOXO3A (Willcox et al. 2008; Flachsbart et al. 2009; Li et al. 
2009) were identified through candidate gene association studies. Genome-wide 
association scans (GWAS) of LLI versus younger controls had only identified APOE with 
genome-wide significance (Nebel et al. 2011; Deelen et al. 2011, 2014). A recent meta-
GWAS has revealed a novel locus on chromosome 5q33.3, a region of unknown 
function, to confer survival beyond 90 years of age (Deelen et al. 2014). 
The genetic variants in the APOE gene were the first to be consistently associated with 
human longevity (Schächter et al. 1994; Zhang et al. 1998; Blanché et al. 2001; 
Christensen et al. 2006). APOE, which plays an important role in regulating lipoproteins 
(Smith 2002; Christensen et al. 2006), has three common alleles namely, Ɛ2, Ɛ3 and Ɛ4, 
which code for the isoforms APOE2, APOE3 and APOE4 respectively (Schächter et al. 
1994). These three isoforms of APOE interact differently with specific lipoprotein 
receptors, thus altering the levels of circulating cholesterols. APOE allele distributions 
vary significantly between LLI and young controls in different  populations (Gerdes et al. 
2000) (Figure 1-5). The Ɛ4 allele of APOE, which has repeatedly been associated with 
increased risk of cardiovascular disease (Kumar et al. 2012) and Alzheimer’s disease (Liu 
et al. 2013), is significantly less frequent in LLI than in younger adults (Schächter et al. 
1994; Garatachea et al. 2014). Therefore, it has been proposed that the APOE Ɛ4 is a 
mortality factor rather than a longevity conferring allele (Gerdes et al. 2000). This led to 
the hypothesis that individuals who attain extreme old age are likely to lack many of the 
disease-predisposing variations (Perls et al. 2002a; Perls and Terry 2003). However, 
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more recently, it has been shown that LLI carry the same number of known disease 
alleles as the general population (Beekman et al. 2010; Sebastiani and Perls 2012). 
Hence, it has been suggested that LLI may have genetic variations that confer protection 
against age-related disease risks (Bergman et al. 2007). Although many biologically 
plausible genes with positive associations with longevity have been described, further 
confirmation of their effects is pending (Christensen et al. 2006). One exception is 
FOXO3A, which is the second gene with variants that are repeatedly associated with 
longevity. 
 
 
Figure 1-5 Frequencies of the three common APOE alleles, Ɛ2, Ɛ3 and Ɛ4 with respect to age 
(Source: McKay et al. 2011).  
 
FOXO3A, a gene that encodes an evolutionarily conserved key transcription factor of the 
IIS pathway, is one of the homologues of daf-16 in C. elegans. It is known that the daf-16 
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transcription factor significantly influences metabolism and lifespan in model organisms 
(Ogg et al. 1997; White 2003; Giannakou et al. 2004). These aspects suggested FOXO3A 
as a promising candidate for genetic studies of human longevity. In 2008, Willcox et al. 
(2008) first described a statistically significant association of variants in the FOXO3A 
gene with longevity in long-lived American men of Japanese ancestry. Later, several 
case-control studies confirmed the association in German (Flachsbart et al. 2009), Italian 
(Anselmi et al. 2009), Chinese (Li et al. 2009), American (European descent) 
(Pawlikowska et al. 2009) and Danish (Soerensen et al. 2010) populations.  A recent 
meta-analysis has further validated the strong association between variants in the 
FOXO3A gene and longevity (Bao et al. 2014). In all these studies, the genetic variants 
associated with longevity are intronic and are not linked to known coding variants. So 
far, neither the functional variant in FOXO3A is known, nor are the mechanisms through 
which human longevity is influenced. A recent study proposed that coding variants of 
the FOXO3A may not be key players and intronic variants may be more important 
(Donlon et al. 2012).   
Although the estimated genetic contribution to longevity is around 20-30%, variations in 
only two genes (APOE and FOXO3A) have been replicated in multiple populations. The 
effect sizes of these longevity-associated variants are small with odds ratios for survival 
to age 100 being 1.26 and 1.45 for FOXO3A and APOE, respectively (Wheeler and Kim 
2011). In other words, these variants account for only a small portion of the estimated 
genetic contribution to human longevity. A large part of the reported heritability 
therefore remains to be explained. 
Given the complexity of the interacting mechanisms and the involvement of possibly   
numerous genes with small effects (Christensen et al. 2006), it has been difficult to 
identify additional variants that influence longevity, and to replicate these results in 
independent samples. The genetic approaches in longevity research have not been as 
successful in identifying the genes underlying the essential mechanisms as in other 
complex phenotypes, for instance, inflammatory bowel disease (Franke et al. 2010). 
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Therefore, new avenues are needed to identify additional longevity-associated genes 
and the underlying molecular mechanisms. One approach has been to perform 
transcriptome studies in the field of human longevity.   
  
1.4 Previous transcriptome studies in human longevity 
The transcriptome of an individual reflects the influence of genetic variation as well as 
the response to the environment (Deelen et al. 2013). Investigating the transcriptomes 
of LLI could provide insights into the biological processes associated with longevity. The 
advent of the whole genome microarrays provided the opportunity to study whole 
human transcriptomes in a high-throughput approach. Since then, several explorative 
studies have been performed to identify the transcriptomic profiles marking human 
longevity. Transcriptional profiles of various tissues, including brain (Hong et al. 2008; Lu 
et al. 2004), eye (Segev et al. 2005), kidney (Rodwell et al. 2004), skin (Lener et al. 2006), 
lymphocytes (Hong et al. 2008), skeletal muscles (Zahn et al. 2006) and blood (Harries et 
al. 2011; Passtoors et al. 2012; Marttila et al. 2013) have been studied to investigate 
whether there are changes in gene expression levels with age. The expression of some 
genes was found not only to denote the chronological age but also reflect the function 
of the source organs and thus their biological age (Slagboom et al. 2011; Passtoors et al. 
2012). The genes that were differentially expressed with chronological age in different 
tissues have been associated with biological terms like energy metabolism, immune 
response, cell cycle/cell growth, signal transduction, mRNA processing, and 
mitochondrial electron transport chain (Rodwell et al. 2004; Zahn et al. 2006; Hong et al. 
2008; Harries et al. 2011; Passtoors et al. 2012; Marttila et al. 2013).  
Most of the transcriptome studies performed in longevity research use cross-sectional 
designs where LLI are compared to young adults or groups of increasing age are 
examined. As pointed out by a hallmark review in the research field of longevity, the 
main problem in cross-sectional designs is  a lack of appropriate control groups, as 
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cohort-specific characteristics might confound comparisons between LLI and younger 
controls (Christensen et al. 2006). Controls used in these studies originate from other 
birth cohorts than the LLI and thus the differences in two samples might confound the 
observations. Moreover, with cross-sectional designs, it is not possible to distinguish 
which changes in gene expression are causal and which are consequential to longevity 
(Passtoors et al. 2008). To address these constraints, a few studies have been performed 
using a family-based design, in which LLI are compared to their middle-aged offspring, 
and the middle-aged offspring are further compared to similar-aged controls from the 
general population (Passtoors et al. 2012). Another approach is to use longitudinal study 
designs, where individuals from a specific birth cohort are followed over time. Although 
longitudinal designs are less prone to biases that are associated with the selection of 
controls, it is difficult to perform such studies due to logistical challenges (Christensen et 
al. 2006). As of now, prospective designs have been used in large epidemiological 
studies but not in transcriptomics.  
Besides study design problems, limited sample sizes and limited availability of relevant 
tissue are the major problems in longevity research. Only few large transcriptome 
studies have been performed to elucidate molecular patterns associated with longevity 
(Harries et al. 2011; Passtoors et al. 2012; Marttila et al. 2013). The majority of 
transcriptome studies were performed using whole blood, as blood is one of the easiest 
accessible biomaterials. Since blood is in contact with all tissues, it may also reflect in 
part the physical health of the whole body (Passtoors et al. 2012). In addition, whole 
blood shares significant similarities with other tissues on a transcriptome level (Sullivan 
et al. 2006). Therefore, studying gene expression in blood is both biologically meaningful 
and practical in the field of human longevity. However, while performing transcriptome 
studies using whole blood, different blood cell populations must be considered. The 
differences in blood cell counts between LLI and younger controls may confound 
observed changes in gene expression (Deelen et al. 2013). Thus, differential gene 
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expression observed in whole blood transcriptome studies should be adjusted for blood 
cell subsets.     
 
1.5 RNA sequencing in longevity research 
Many technologies have been developed over the years to quantify gene expression, 
including Northern blotting, quantitative reverse transcription polymerase chain 
reaction (qRT-PCR), hybridization- and sequencing-based approaches. Among these, 
microarrays and the recent RNA-sequencing (RNA-seq) are capable of analyzing 
thousands of genes simultaneously.  
Microarrays contain thousands of different oligonucleotides - short single stranded DNA 
molecules, which are immobilized on to the solid support (glass slide, silicon chips or 
nylon membrane). The principle behind microarray technology is hybridization between 
DNA probes on the array and labeled RNA molecules derived from the sample of 
interest. The amount of mRNA hybridized to each probe indicates the corresponding 
gene expression, which can be estimated from the hybridization signal (Tarca et al. 
2006).   
Although microarrays are the most popular approach for gene expression studies and 
are relatively inexpensive, they pose several limitations. For instance, the accuracy of 
expression measurements suffer from background noise, especially for transcripts 
present in low abundance. Furthermore, probes differ considerably in their 
hybridization properties. Thus, hybridization results from a single sample may not 
provide a reliable measure of the relative expression of different transcripts. Finally, 
usage of microarray technology limits the interrogation to only those genes for which 
probes are designed (Marioni et al. 2008).  
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In contrast to microarray technology, RNA-seq involves direct sequencing of transcripts 
using high-throughput sequencing technologies. The expression of each transcript is 
measured by the number of sequenced fragments that align to the transcript, which is 
expected to correlate with its abundance level (Rapaport et al. 2013). RNA-seq has been 
used to measure gene expression levels and has the potential to overcome the 
limitations posed by microarrays. Unlike microarrays, RNA-seq is not limited to 
investigating transcripts that correspond to existing genomic sequence but can also be 
applied to non-model organisms whose genomic sequences are yet to be determined 
(Wang et al. 2009). Besides, RNA-seq permits examining novel transcripts (Hutchins et 
al. 2012), allele-specific expression (Degner et al. 2009), and alternative splicing (Pan et 
al. 2008). Furthermore, RNA-seq has very low background noise because DNA 
sequences can be unambiguously mapped to unique regions of the genome. 
Additionally, RNA-seq does not have an upper limit for quantification and thus has a 
large dynamic range of expression levels. Finally, RNA-seq has high technical and 
biological reproducibility (Wang et al. 2009). Therefore, RNA-seq is becoming a powerful 
technology for transcriptomic studies. 
Since RNA-seq can provide more accurate and reliable genome-wide gene expression 
data than any alternative method, it has been used to study gene expression in several 
diseases, including Alzheimer’s (Twine et al. 2011), schizophrenia (Fillman et al. 2012; 
Hwang et al. 2013; Sainz et al. 2013), renal cell carcinoma (Xiong et al. 2014), lung 
cancer (Cheng et al. 2012) and immune-mediated diseases (Zhang et al. 2012). But RNA-
seq based transcriptome profiling has not been performed in longevity research thus 
far. This study provides the first comprehensive insights into the transcriptome of LLI 
using RNA-seq.      
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1.6 Objectives of the study 
The overall aim of this investigation is to gain knowledge about the essential 
mechanisms that let some people survive to an exceptional age in good health. The 
information obtained from studies as this one represent a starting point for approaches 
aiming to extend the health span of the elderly and thus may ease the pressure on 
healthcare systems. The specific objectives of this thesis are: 
 To identify the molecular patterns associated with human longevity by 
comparing the transcriptomes of LLI with those of young controls. 
 To investigate the heritability of transcriptional activity by using monozygotic 
and dizygotic twins. 
 To examine the influence of natural genetic variability on gene expression by 
performing expression quantitative trait loci (eQTL) analysis, which provides an 
opportunity 1) to determine the primary (genetic) basis of the regulation of gene 
expression and 2) to gain insights into otherwise unknown genotype-phenotype 
correlations. 
 To investigate the genotype-age interaction effects on the genes that are 
differentially expressed between LLI and young controls.   
To achieve the above mentioned objectives, a large number of probands were recruited: 
55 LLI and 73 young controls from Germany along with 48 long-lived twins, 48 middle-
aged twins, 10 unrelated LLI and 10 unrelated middle-aged individuals from Denmark. 
The transcriptomes from whole blood of all the individuals were sequenced with a state-
of-the-art technology, RNA-seq. The obtained data was subsequently analyzed using a 
pipeline, which was developed during the course of this study, to accomplish the 
specific goals.  
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2 Materials and Methods 
The work contained in this thesis was performed according to the workflow depicted in 
Figure 2-1. German samples (see Table 2-1) used in this study were recruited by the 
PopGen Biobank in Kiel and Danish samples were recruited by our Danish collaborators. 
RNA and DNA extraction, RNA-sequencing and genotyping were performed on the 
platforms at the Institute of Clinical Molecular Biology, Kiel. Each step is described in 
detail in the following sections.    
 
 
 
Figure 2-1 Analysis pipeline/workflow used in the present study 
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2.1 Study participants and sample collection 
An overview of the samples used in this study is provided in Table 2-1. All the German 
subjects were recruited between October 2009 and November 2011 from different 
regions of Germany. The recruitment was carried out as previously described (Nebel et 
al. 2005). In brief, the contact with the participants was established by obtaining their 
names and addresses from local registry offices. At first, a letter explaining the study 
and seeking permission to send a questionnaire and a blood sampling kit was sent out to 
all potential participants. Subjects were advised to fill out the questionnaire and take a 
blood sample (20-ml) with the help of their general practitioner. A complete summary 
of the socioeconomic condition, quality of life, and health status of the subjects was 
recorded from the questionnaires. Primary criteria for inclusion in the study population 
were ability to perform daily activities on their own, good health and absence of overt 
severe diseases. All probands signed a written informed consent to participate in the 
study. Approval for the study was received from the Ethics Committee of the Christian-
Albrechts-University, and also from local data protection authorities. 
All the Danish samples were recruited by our collaborators at the University of Southern 
Denmark, Odense and sent to us. The approval to use these samples in this study was 
received from the Ethics Committee in Odense, Denmark. 
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Table 2-1 Overview of the study participants 
Study groups (Country) Age range 
in years 
No. of females / No. 
of males (total 
number) 
Total (N)  
Young individuals (Germany) 20-55 45/28 (73)  
 
244 
Long-lived individuals (Germany) 91-104 40/15 (55) 
Middle-aged twins (Denmark) 58-60 32/16 (48) 
Long-lived twins (Denmark) 83-92 32/16 (48) 
Middle-aged unrelated individuals (Denmark) 58-60 4/6 (10) 
Long-lived unrelated individuals (Denmark) 83-92 8/2 (10) 
 
2.2 Extraction of RNA and DNA from blood samples 
Total RNA including miRNA was extracted from whole blood samples collected in 
PAXgene Blood RNA tubes (QIAGEN). These tubes contain a reagent that lyses blood 
cells and immediately stabilizes intracellular RNA in order to prevent RNA degradation. 
RNA molecules longer than 18 nucleotides were purified from the stabilized blood 
samples using the PAXgene Blood miRNA Kit (QIAGEN) following the manufacturer’s 
instructions. Briefly, lysed blood cells were first centrifuged, washed and subsequently 
subjected to proteinase K treatment. The cell lysate was then homogenized using 
PAXgene shredder spin column. Isopropanol was added to optimize binding conditions, 
and the lysate was subjected to PAXgene RNA spin column. Total RNA bound to the 
PAXgene silica-membrane was treated with DNase to remove genomic DNA 
contamination. RNA was washed and eluted in buffer.  
DNA was extracted from EDTA whole blood samples using the Invisorb Blood Giga Kit 
following the manufacturer’s protocol. In brief, erythrocytes were first lysed and 
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removed. In the subsequent step, leukocytes were isolated from interfering hemoglobin 
and were subjected to second lysis step. Afterwards, DNA was separated from protein 
fragments using proteinase K and precipitated by adding 96% ethanol to the lysate. The 
precipitated DNA was washed with 70% ethanol, dried and resuspended in low salt 
buffer for further downstream applications.  
 
2.3 Library generation for RNA sequencing 
Paired-end libraries were prepared using the Illumina TruSeq RNA Sample Preparation 
Kit (low-throughput protocol) following the manufacturer’s protocol. Briefly, the 
messenger RNA (mRNA) was purified from the total RNA using polyA selection and then 
chemically fragmented. Following the fragmentation, the first cDNA strand was 
synthesized using reverse transcriptase and random primers. Next, the second cDNA 
strand was synthesized to create double-stranded cDNA. The cDNA fragments were 
then subjected to end repair process, addition of a single ‘A’ nucleotide to the 3’ end, 
and ligation of the adapters. The ligated products were subsequently purified and 
amplified with PCR to produce a final double-stranded cDNA library. The libraries were 
quality-checked using the Agilent Bioanalyzer 2100. The Illumina TruSeq RNA Sample 
Preparation Kit employed here does not preserve the strandedness of the RNA 
transcripts.  
 
2.4 RNA sequencing 
The paired-end libraries were sequenced using the HiSeq 2000 technology (Illumina). 
Before sequencing, the prepared libraries were first subjected to bridge amplification in 
order to generate clonal clusters. Single-molecule DNA fragments were amplified in a 
flow cell whose surface consists of covalently attached oligonucleotides which are 
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complementary to the adapters ligated to the library fragments. To obtain clonal 
clusters, DNA fragments were first hybridized to the oligonucleotides on the flow cell 
and then amplified by bridge amplification (Figure 2-2). During this process, the 
hybridized DNA fragments arch over and hybridize to an adjacent oligonucleotide on the 
flow cell. In the next step, DNA polymerase was used to copy the DNA fragments from 
the hybridized oligonucleotides, thus forming double stranded DNA (dsDNA) bridges. 
These dsDNA bridges were subsequently denatured to form two single stranded DNA 
(ssDNA) strands that again arch over and hybridize to adjacent oligonucleotides. This 
process was repeated multiple times, which results in millions of individual, dense clonal 
clusters. This cluster generation step was carried out on the Illumina cBOT instrument.  
 
Figure 2-2 Bridge amplification to obtain clonal clusters. It is composed of two basic steps: initial 
priming and extending of the single-stranded, single-molecule template, and bridge 
amplification of the immobilized template with immediately adjacent primers to form clusters 
(Source: Metzker 2010).   
 
The generated clusters were sequenced using Illumina’s well-established “sequencing-
by-synthesis” (SBS) chemistry. SBS chemistry employs four reversible terminator 
nucleotides (Figure 2-3), each labeled with a different fluorescent dye and a chemically 
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inactivated 3’-OH group. Sequencing was initialized by hybridizing primers to the 
templates on the flow cell. Next, four fluorescently labeled nucleotides were added that 
compete for incorporation into the growing DNA strands. After incorporation of a single 
nucleotide, the free nucleotides were washed off and the fluorescence from the 
incorporated nucleotide was measured by laser excitation and recorded in an imaging 
step. Subsequently, the fluorescent dye was cleaved and the procedure was repeated 
for the adjacent base. Since these were paired-end libraries, sequencing was carried out 
from both ends of the adapter ligated fragments. 
 
Figure 2-3 Four-color reversible termination method used by Illumina (Source: Metzker 2010).  
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2.5 Primary and secondary analysis of the sequence data 
Primary analysis (i.e., image analysis, base calling and quality scoring) was performed 
on-instrument (Illumina, HiSeq 2000). During the base calling phase, the calls of the 
mixed clusters cannot be determined accurately. To address this issue, Illumina uses a 
built-in chastity filter to identify clusters with a low signal to noise ratio. Chastity for a 
given base call is defined as follows: 
chastity  
                 
                                 
     (1) 
By default the chastity threshold is 0.6. Clusters pass the filter if no more than one base 
call in the first 25 cycles has a chastity of below 0.6. The reads that failed the Illumina 
chastity filter were removed using the Illumina CASAVA-1.8 FASTQ filter v0.1. After 
chastity filtering, the quality of the reads was further assessed using FASTQC v0.10.0 
(Andrews 2010). 
The raw reads were then mapped against the human reference (hg19) using TopHat 
v2.0.4 (Trapnell et al. 2009), a fast splice junction aligner. The most recent UCSC genome 
build (hg19) and a pre-built index were downloaded from the TopHat homepage 
(http://tophat.cbcb.umd.edu/) and used as a reference. TopHat aligned reads to the 
reference genome in two phases. In the first phase, TopHat used Bowtie2 v2.0.0 
(Langmead and Salzberg 2012) to align all reads to the reference genome allowing no 
more than 2 mismatches. Reads that were not mapped in the first phase were set aside. 
TopHat then generated a database of putative exons and potential splice junctions from 
the aligned reads. The unmapped reads from the first phase were then aligned to 
putative exons in this database while a seed and extend alignment method was 
employed to align reads to possible splice sites. The alignments were conducted using 
TopHat’s default parameters except for the below mentioned: 
--mate-inner-dist (r) and --mate-std-dev: The mean inner distance between pairs and 
the standard deviation for the distribution on inner distances between pairs were 
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determined for each sample by aligning a subset of reads (around 5 million) against the 
human reference (hg19) using BWA v0.5.9 (Burrows-Wheeler Aligner) (Li and Durbin 
2009). The insert size and standard deviation values were calculated from the obtained 
SAM files (Sequence Alignment/Map, http://samtools.sourceforge.net) using Picard’s 
CollectInsertSizeMetrics (http://picard.sourceforge.net/). The combined read length was 
then subtracted from the calculated insert size to obtain the mate inner distance. These 
values were passed to TopHat for alignment. 
 
2.6 Gene assembly and quantification 
Aligned reads were processed using Cufflinks v2.0.2 (Trapnell et al. 2010). Cufflinks 
constructed a directed acyclic read overlap graph and assembled transcripts by finding a 
minimal path cover through minimum cost maximum matching. Additionally, the gene-
level expression was calculated and reported in terms of fragments per kilobase of exon 
per million fragments mapped (FPKM). The supplied reference annotation (hg19) was 
used by Cufflinks as the basis for the transcript assembly and gene-level abundance 
estimation. Cufflinks was instructed to run a bias detection and correction algorithm 
(Roberts et al. 2011) in order to improve accuracy of abundance estimates by providing 
a multifasta reference file (hg19) via a command option --frag-bias-correct. Additionally, 
other command line options mentioned in Table 2-2 were enabled. 
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Table 2-2 List of command line options used in cufflinks while assembling and quantifying genes.  
2.7 Detection of differentially expressed genes 
The obtained FPKM estimates for genes were processed using custom Perl and R scripts 
to identify the differentially expressed genes. Firstly, FPKM estimates from all the 
German samples were constructed into a matrix where each row represented a gene 
and each column represented a sample. Between-sample normalization was carried out 
using the quantile normalization method in order to make genes comparable between 
samples, and FPKM estimates were then log2 transformed. Only those genes expressed 
(i.e., log2 FPKM > 0) in more than 5% of the samples were considered and differential 
analysis was conducted using a non-parametric Wilcoxon rank sum test. To address the 
issue of multiple testing, p-values were adjusted using Benjamini and Hochberg’s 
method (Benjamini and Hochberg 1995). A p-value cutoff of 0.001 was applied for 
selecting the differentially expressed genes. 
 
Command line options Function 
--upper-quartile-norm Normalizes FPKM values by the upper quartile of the number 
of reads mapped to individual loci instead of the total 
number of sequenced reads. This can improve the robustness 
for less abundant genes while performing differential 
expression analysis 
--multi-read-correct Instructs cufflinks to do an initial transcript abundance 
estimation procedure to more accurately weight reads 
mapping to multiple positions in the genome  
--compatible-hits-norm Considers only those reads that are compatible with 
reference transcript as the number of mapped reads while 
estimating FPKM values 
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2.8 Filtering blood cell-specific genes 
It is evident that hematopoietic changes occur with advanced age (Pang et al. 2011; 
Kuranda et al. 2011). Since whole blood samples were used in this study, differential 
expression of few genes may be attributed to age-related hematopoietic changes. To 
address this issue, the differentially expressed genes that highly correlated (r ≥ 0.8) with 
blood cells (Palmer et al. 2006) were filtered and omitted from further analysis.  
 
2.9 Heritability estimation  
The gene expression data from the Danish twins was subjected to between-sample 
normalization, and log2 transformed as described for the German samples. The genes 
which were expressed (i.e., log2 FPKM > 0) in more than 95% of the samples were 
considered for heritability estimation. The heritability of gene expression 
(transcriptional activity) was estimated using standard structural equation modeling 
(SEM) (Neale et al. 1992), which is a statistical technique extensively used in 
quantitative genetics to estimate genetic and environmental influences on phenotypes 
of interest. Under classical biometric analyses of twin data, the total phenotypic 
variance in quantitative traits can be partitioned into two components, namely, variance 
that is associated with genetic effects, and variance that is associated with 
environmental effects. This can be represented as below: 
    VP = VG + VE  (2) 
Where: 
VP = total phenotypic variance in a trait 
VG = genetic variance 
VE = environmental variance  
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The genetic variance can be further decomposed into additive and dominance 
components and the environmental variance can be decomposed into shared and non-
shared environmental components. Thus, the total phenotypic variance can be written 
as: 
VP = VA + VD + VE + VC (3)   
Where:  
 VA = additive genetic variance 
VD = dominance genetic variance (non-additive genetic effects that represent 
interactions between alleles at a locus)  
VE = unique environmental variance (environmental exposures unique to each    
twin) 
VC = common environmental variance (environmental exposures shared by both 
twins) 
 
These different variance components can be estimated using twin data, since 
monozygotic (MZ) twins share all additive (A) and dominant (D) genetic effects whereas 
dizygotic (DZ) pairs share 50% of additive (A) and 25 % of dominant (D) genetic effects 
(Rijsdijk and Sham 2002). Also, both MZ and DZ pairs have equal shared environmental 
effects.  
The heritability of transcriptional activity was estimated by considering only the additive 
genetic effects. Thus, the ACE model was fitted using biometric modeling (SEM), and 
was allowed to compete with more parsimonious models, namely, AE, CE and E. The 
best model was chosen based on the Akaike Information Criterion (AIC) (Akaike 1974) 
for non-nested models and the likelihood ratio test for nested models. The final 
heritability estimate was obtained from the best model. The R statistical package called 
“Mets” (v0.1-13) (http://CRAN.R-project.org/package=mets) was used for the biometric 
modeling.    
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2.10 Genotyping 
DNA samples from all the German individuals (73 young and 55 LLI) were subjected for 
genotyping. In case of the Danish samples, only one individual from each MZ twin pair 
was selected as MZ twins are genetically identical. Therefore, 22 MZ, 50 DZ twins and 20 
unrelated individuals from Denmark were used. In total, DNA samples from 220 
individuals were genotyped using HumanOmniExpress BeadChips (Illumina). The arrays 
monitor 730,525 single nucleotide polymorphisms (SNPs) across the genome. The 
infinium HD (High-Density) Assay was used for genotyping following the manufacturer’s 
instructions. In brief, the samples were subjected to whole genome amplification 
followed by fragmentation. In subsequent steps, the unlabeled DNA fragments were 
hybridized to the BeadChip and extended with single labeled nucleotides followed by 
signal detection using a scanner. The resulting genotype data was subjected to basic 
quality control using the GenomeStudio software (Illumina). 
Additionally, two APOE variants namely, rs429358 and rs7412, that collectively 
determine the APOE genotype (Lindahl-Jacobsen et al. 2013), and three FOXO3A 
variants (rs3800231, rs2764264 and rs4945816) (Flachsbart et al. 2009) that are known 
to be associated with longevity were genotyped using predesigned Taqman genotyping 
assays (Life Technologies). These variants were genotyped in all the above mentioned 
samples, except in 4 unrelated individuals from Denmark due to a lack of DNA. The 
genotyping was performed according to the manufacturer’s instructions. Briefly, the 
reaction mixtures consisting of DNA, PCR reaction mix components, and the TaqMan 
probes were prepared and the reaction was carried out on the 7900HT Real-time PCR 
system (Life Technologies). After completion of the run, genotypes were determined by 
measuring the fluorescence with the Sequence Detection Systems (SDS, Applied 
Biosystems) 2.0 software.   
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2.11 Expression quantitative trait loci analysis – investigating cis-
regulation of gene expression 
Expression quantitative trait loci (eQTL) analysis is a statistical method that correlates 
gene expression with genotype data. eQTL analysis provides an opportunity to 
investigate the influence of genetic variation on mRNA expression levels. Genetic 
variants can influence gene expression in many ways, for example by altering the 
promoter or coding sequences of genes, their splice junctions, or other gene regulatory 
elements. A gene can be regulated by two types of eQTLs, namely cis and trans. Variants 
that affect genes that are in their close proximity are termed cis regulators and variants 
that affect genes elsewhere on the genome are referred to as trans regulators.  
The gene expression and genotype data from the German and Danish samples were 
correlated separately. Since the samples were anonymized before genotyping, both 
gene expression and genotype data were passed on to a trustee (PopGen biobank) in 
order to match them. The obtained matched data contained no true sample identity. As 
the German samples were from unrelated individuals and the Danish samples were 
from twins, two different approaches were employed to perform the eQTL analysis. The 
details are described below.   
In case of the German samples, the cis-eQTL analysis was carried out for the genes that 
were differentially expressed between young and long-lived individuals. The analysis 
was performed with a 1-Mb window, which means only those variants that were located 
within a 1-Mb sequence both upstream and downstream from the starting and end 
points of the gene were included in the analysis. Some variants were used more than 
once because of overlapping intervals. The selected variants within the 1-Mb window 
were analyzed for association with gene expression using PLINK v1.07 (Purcell et al. 
2007). PLINK is a well-established command-line tool, which focuses on analysis of 
genotype/phenotype data. It provides features that facilitate inclusion of multiple 
covariates when testing for quantitative trait and genetic variant association. Cis-eQTL 
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analysis was performed on each differentially expressed gene using a linear model 
(option --linear), in which age and gender were provided as covariates. Only those 
variants with minor allele frequency above 1% and missingness below 5% (variants 
having missing values in less than 5% of the individuals) were used. The obtained cis-
eQTLs were adjusted for multiple testing using Benjamini and Hochberg’s method 
(Benjamini and Hochberg 1995). The associations with a p-value ≤ 0.05 were considered 
as potential cis-eQTLs. 
In case of the Danish twins, the cis-eQTL analysis was performed on those genes which 
had heritable transcriptional activity. As described for the German samples, a 1-Mb 
window was used. The analysis was carried out using Genome-wide Efficient Mixed 
Model Association (GEMMA) (Zhou and Stephens 2012). As a first step of the analysis, 
four input files containing genotypes, phenotypes (gene expression), covariates and 
relatedness matrix were prepared as per GEMMA’s requirements. The gene expression 
and genotype data was prepared in the PLINK binary ped format. Since MZ twins are 
genetically identical, only one of each twin pair was genotyped and the same data was 
used for the other twin. The standardized relatedness matrix file was constructed in an 
n x n format, where each row and each column corresponds to individuals in the same 
order as in the genotype file. The value in ith row and jth column indicates the relatedness 
between ith and jth individuals. Also, a covariate file containing age and gender 
information was provided. GEMMA then performed the association test between gene 
expression and genotype data by fitting a univariate linear mixed model. Only those 
variants that had missingness below 5% and minor allele frequency above 1% were 
analyzed. The cis-eQTLs for each gene were corrected for multiple testing using 
Benjamini and Hochberg’s method and a p-value cutoff of 0.05 was applied. 
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2.12 Investigation of genotype-age interaction effects on gene 
expression 
The eQTL analysis identifies the variants that influence the expression of a gene, but it 
cannot identify the changes in the influence of variants on gene expression due to their 
interaction with age. Thus, the contribution of genotype-age (G×A) interaction to the 
variance observed in differentially expressed genes was investigated. For this analysis, 
only the differentially expressed genes with at least one significant cis-eQTL were 
considered. The G×A interaction for each gene and the most significant cis-eQTL were 
investigated by employing a linear mixed model. Two models namely, a full model with 
a G×A interaction term and a reduced model without an interaction term, were fitted 
along with age, gender (fixed effects) and sequencing batch number (random effects), 
using a R package called lme4. The best fit model was selected based on AIC. If the best 
fit model was a full model with a G×A interaction term, then the gene was considered to 
have a G×A interaction effect on its expression.       
 
2.13 Functional analysis: Gene ontology 
Gene ontology (GO) is widely used to describe biological features of genes and their 
products. It provides a controlled vocabulary to categorize the functions of genes and 
gene products in terms of their biological processes, molecular functions and cellular 
components. GO analysis requires two input gene lists namely, a reference list that 
comprises all the genes considered in an experiment and a query list which contains the 
genes of interest. The analysis was carried out on different query lists as mentioned 
below:   
a) Differentially expressed genes between long-lived and young individuals 
b) Differentially expressed genes that were associated with cis-eQTLs  
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c) Differentially expressed genes that were not associated with cis-eQTLs  
d) Differentially expressed genes that were associated with cis-eQTLs and also 
exhibited G×A interaction 
e) Genes that showed heritable transcriptional activity 
f) Genes that showed heritable transcriptional activity and cis-eQTL association 
Significant enrichment or depletion of GO terms was identified for each query list using 
the two-sided Fisher’s exact test, followed by Benjamini and Hochberg’s correction for 
multiple testing. 
 
2.14 Biological validation using the Danish samples 
In order to validate the results from the differential expression analysis and the cis-eQTL 
analysis (from German samples) Danish samples were used. Since the German dataset 
consisted of unrelated individuals and the Danish dataset consisted of twins, one 
individual was selected from each twin pair in order to create an equivalent validation 
dataset. Additionally, 10 unrelated cases (83-92 years) and 10 unrelated controls (58-60 
years) from Denmark were used in the validation dataset. In total, 68 samples (48 
individuals selected from 48 twin pairs, of which 24 were cases and 24 were controls, 
and additional 10 cases and 10 controls) were used in the validation dataset. The 
transcriptome data from these 68 samples was analyzed as described previously 
(section 2.7) to identify and validate the differentially expressed genes detected in the 
German dataset. 
Furthermore, the genotype and the expression data from the 68 Danish samples were 
used in order to validate the results from the cis-eQTL analysis. The analysis was carried 
out using PLINK as described in section 2.11.   
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2.15 Technical validation using real-time qPCR 
An independent laboratory technique, quantitative PCR (qPCR) was used to validate the 
results from the transcriptome sequencing. The German samples (Table 2-1) which were 
used for the transcriptome sequencing were employed in this analysis. However, five 
samples (three young individuals and two LLI) were not included in the analysis due to 
lack of RNA. In order to select candidate genes for validation, the differentially 
expressed genes were first ranked based on their effect size (fold change), significance 
in the analysis between young and long-lived individuals, and regulation of their 
expression by cis-eQTLs. Based on the ranks, 80 candidate genes (see Table 3-5) were 
selected for validation using RT-qPCR. Additionally, three groups of controls were 
included, namely:  
a) four endogenous control genes (see Table 2-3)  
b) five genes which are known or presumed to have a genetic association with 
longevity, but were not differentially expressed between young and LLI (see 
Table 2-3) 
c) five genes with no or low variation in expression levels among the samples (see 
Table 3-4)  
Real-time PCR (RT-PCR) was performed according to the manufacturer’s guidelines (Life 
Technologies) using a 7900HT Real-time PCR system (Applied Biosystems, California, 
USA). In brief, total RNA was reverse-transcribed to cDNA using the High Capacity RNA-
to-cDNA kit and the quantity of the cDNA was measured by determining the UV 
absorbance (A260/A280) method. The reaction mixtures consisting of cDNA samples and 
PCR reaction mix components were prepared and then loaded on microfluidic cards, 
containing the selected TaqMan Gene Expression assays. The reactions were carried out 
on the 7900HT Real-time PCR system (Applied Biosystems, California, USA). Upon 
completion of the run, the data was preprocessed by the Sequence Detection System 
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(SDS) 2.0 software. Gene expression levels were measured using the delta-delta CT 
method (Livak and Schmittgen 2001). The three above mentioned groups of control 
genes were investigated for variation in the expression levels across the samples and 
the control group with minimum variation was selected as the control. In this case, 
genes from group (b) were selected as controls and the median of their expression 
levels was used to normalize the expression levels of the candidate genes. Differences 
between young and long-lived individuals were determined using the Wilcoxon rank 
sum test and the p-values were corrected for multiple testing using Benjamini and 
Hochberg’s method (Benjamini and Hochberg 1995). 
Table 2-3 First two groups of controls and their TaqMan assays used for validation. 
Gene symbol Gene name TaqMan assay ID 
Endogenous controls 
18s rRNA - Hs99999901_s1 
PPIB peptidylprolyl isomerase B (cyclophilin B) Hs00168719_m1 
TRAP1 TNF receptor-associated protein 1 Hs00212474_m1 
PGK1 phosphoglycerate kinase 1 Hs00943178_g1 
Known or presumed to have a genetic association with longevity, but not differentially expressed 
APOE apolipoprotein E Hs00171168_m1 
ACE angiotensin I converting enzyme Hs00174179_m1 
SIRT3 sirtuin 3 Hs00953477_m1 
LMNA lamin A/C Hs00153462_m1 
FOXO3 forkhead box O3 Hs00818121_m1 
  
Results                                             
34 
 
3 Results 
3.1 General mapping statistics 
In the presented study, transcriptome libraries from blood samples were sequenced in 
244 individuals using Illumina’s Truseq technology. For each individual, an average of 48 
million (SD=14M) sequences was generated. When Illumina’s chastity filter was applied 
to the raw sequence data in order to filter the sequences based on the signal purity, on 
an average approximately 90% (SD=4.9) of the sequences passed the filter. Out of these, 
an average of 85% (SD=4) of the sequences mapped to the human reference (hg19 
build). 
 
3.2 Genome-wide transcriptome profiling 
3.2.1 Differential expression between long-lived and young individuals 
Transcriptomes from young (n=73, age=20–55 years) and long-lived German individuals 
(n=55, age=91–104 years) were analyzed to identify differentially expressed genes. Gene 
expression levels were determined with the Cufflinks software (see 2.6), which reported 
gene abundance as FPKM. The annotation file (hg19) used in this context contained 
23,368 genes. Out of these, 19,991 genes were expressed (i.e., log2 FPKM > 0) in at least 
5% of the samples and were considered for the differential expression analysis. To 
ensure high statistical data reliability, stringent cutoff criteria (Benjamini – Hochberg 
corrected p-value ≤ 0.001; false discovery rate (FDR) ≤ 1%) were applied. Appling this 
filter, a total of 6,217 genes were found to be differentially expressed between long-
lived and young individuals. Of these genes, 3,525 were downregulated and 2,689 genes 
were upregulated in LLI, revealing that the differential gene expression pattern was 
dominated by downregulated transcriptional activities in LLI. In addition to up- and 
downregulation of differentially expressed genes, for three genes an on/off effect could 
be observed, which cannot be quantified as a fold change: for a given gene, if the 
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median expression value of the young individuals was zero while the median expression 
value of the LLI was not zero, the corresponding gene was considered switched on in LLI 
(LOC100132735). The opposite effect was observed as well (SLC7A3, OR10G2). Among 
the differentially expressed genes, 178 showed significant gender effect (Benjamini – 
Hochberg corrected p-value ≤ 0.05; FDR ≤ 5%). A list of these genes is provided in the 
supplementary material (Table 8-1). The top 50 upregulated and downregulated genes 
in LLI (after filtering blood cell-specific genes (see 3.2.2)) are listed in Table 3-1 and 
Table 3-2, respectively. The remaining differentially expressed genes are provided as an 
electronic attachment.  
Table 3-1 The top 50 genes which were upregulated in long-lived individuals. 
Gene symbol Gene name p-value* 
Fold 
change 
DNAJC1  DnaJ (Hsp40) homolog, subfamily C, member 1 3.12E-13 1.593 
LOC100271722 hypothetical protein LOC100271722 9.38E-12 1.817 
PHLDA3  pleckstrin homology-like domain, family A, member 3 1.36E-11 3.143 
ANKRD22  ankyrin repeat domain 22 1.40E-11 2.913 
ODF3B  outer dense fiber of sperm tails 3B 1.59E-11 2.102 
FCGR1A  Fc fragment of IgG, high affinity Ia, receptor (CD64) 1.67E-11 3.207 
MS4A4A  membrane-spanning 4-domains, subfamily A, member 4A 3.08E-11 2.491 
SAP30  Sin3A-associated protein, 30kDa 6.73E-11 1.740 
POLB  polymerase (DNA directed), beta 2.03E-10 1.707 
PSMB8  proteasome (prosome, macropain) subunit, beta type, 8 2.27E-10 1.237 
VAMP5  vesicle-associated membrane protein 5 2.27E-10 2.163 
PAQR4  progestin and adipoQ receptor family member IV 2.81E-10 1.717 
ZBP1  Z-DNA binding protein 1 3.12E-10 1.480 
FCGR1C  Fc fragment of IgG, high affinity Ic, receptor (CD64), pseudogene 3.66E-10 3.575 
TRIP4  thyroid hormone receptor interactor 4 4.45E-10 1.441 
SLC27A3  solute carrier family 27 (fatty acid transporter), member 3 4.50E-10 1.304 
HOXB7  homeobox B7 4.70E-10 3.503 
DES  desmin 4.71E-10 2.899 
PDGFRB  platelet-derived growth factor receptor, beta polypeptide 8.29E-10 2.629 
MANEAL  mannosidase, endo-alpha-like 8.60E-10 2.473 
RIPK3  receptor-interacting serine-threonine kinase 3 8.93E-10 1.448 
BATF2  basic leucine zipper transcription factor, ATF-like 2 9.56E-10 2.925 
FAM20A  family with sequence similarity 20, member A 9.66E-10 2.419 
LGALS1  lectin, galactoside-binding, soluble, 1 1.01E-09 1.830 
SQRDL  sulfide quinone reductase-like (yeast) 1.22E-09 1.261 
BLVRA  biliverdin reductase A 1.39E-09 1.673 
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Gene symbol Gene name p-value* 
Fold 
change 
PARP3  poly (ADP-ribose) polymerase family, member 3 1.41E-09 1.585 
SMARCD3  SWI/SNF related, matrix associated, actin dependent regulator of 
chromatin, subfamily d, member 3 
1.49E-09 1.778 
DDO  D-aspartate oxidase 1.55E-09 2.292 
SCO2  SCO2 cytochrome c oxidase assembly protein 1.79E-09 2.223 
CDKN2B-AS1  CDKN2B antisense RNA 1 1.81E-09 2.206 
TP53I3  tumor protein p53 inducible protein 3 1.87E-09 2.080 
CD63  CD63 molecule 1.93E-09 1.234 
IFI35  interferon-induced protein 35 1.93E-09 1.693 
IL18  interleukin 18 (interferon-gamma-inducing factor) 2.34E-09 1.733 
PSME2  proteasome (prosome, macropain) activator subunit 2 (PA28 
beta) 
2.34E-09 1.427 
IGFBP7  insulin-like growth factor binding protein 7 2.99E-09 1.536 
FAM110B  family with sequence similarity 110, member B 3.06E-09 1.573 
RAB24  RAB24, member RAS oncogene family 3.14E-09 1.392 
HSD3B7  hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid 
delta-isomerase 7 
3.18E-09 2.273 
CLIC1  chloride intracellular channel 1 3.85E-09 1.355 
FBXO6  F-box protein 6 4.89E-09 1.511 
APOL4  apolipoprotein L, 4 5.28E-09 2.772 
ETV7  ets variant 7 5.50E-09 3.566 
C5orf56  chromosome 5 open reading frame 56 6.15E-09 1.439 
C11orf75  chromosome 11 open reading frame 75 6.23E-09 1.512 
RASGEF1A  RasGEF domain family, member 1A 6.38E-09 1.591 
TMEM62  transmembrane protein 62 6.48E-09 1.506 
DDB2  damage-specific DNA binding protein 2, 48kDa 6.56E-09 1.534 
C16orf7  chromosome 16 open reading frame 7 6.80E-09 1.686 
*p-value is corrected for multiple testing 
 
Table 3-2 The top 50 genes which were downregulated in long-lived individuals. 
Gene 
symbol 
Gene name p-value* Fold 
change 
LRRN3  leucine rich repeat neuronal 3 9.03E-17 -9.112 
CD248  CD248 molecule, endosialin 1.57E-15 -5.469 
NELL2  NEL-like 2 (chicken) 1.82E-14 -2.332 
NOG  noggin 4.46E-14 -3.949 
ABLIM1  actin binding LIM protein 1 6.13E-14 -2.320 
NT5E  5'-nucleotidase, ecto (CD73) 8.94E-14 -2.841 
CAMK4  calcium/calmodulin-dependent protein kinase IV 1.19E-13 -2.060 
FAM102A  family with sequence similarity 102, member A 1.19E-13 -2.000 
RCAN3  RCAN family member 3 2.30E-13 -2.099 
RASGRF2  Ras protein-specific guanine nucleotide-releasing factor 2 3.42E-13 -2.431 
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Gene 
symbol 
Gene name p-value* Fold 
change 
SERPINE2  serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor 
type 1), member 2 
3.42E-13 -2.790 
NPAS2  neuronal PAS domain protein 2 3.70E-13 -4.513 
SPTBN1  spectrin, beta, non-erythrocytic 1 3.70E-13 -2.269 
N4BP3  NEDD4 binding protein 3 5.59E-13 -2.631 
SFRP5  secreted frizzled-related protein 5 5.59E-13 -12.998 
KLHL3  kelch-like family member 3 5.85E-13 -1.788 
CHMP7  charged multivesicular body protein 7 7.04E-13 -1.591 
GPRASP1  G protein-coupled receptor associated sorting protein 1 7.26E-13 -2.340 
CACHD1  cache domain containing 1 9.12E-13 -5.505 
NIPAL3  NIPA-like domain containing 3 1.48E-12 -1.501 
ZNF549  zinc finger protein 549 1.82E-12 -1.490 
AQP3  aquaporin 3 (Gill blood group) 2.12E-12 -2.174 
EDAR  ectodysplasin A receptor 3.08E-12 -3.476 
ZFYVE9  zinc finger, FYVE domain containing 9 3.08E-12 -1.733 
CCR7  chemokine (C-C motif) receptor 7 3.40E-12 -2.111 
NR3C2  nuclear receptor subfamily 3, group C, member 2  5.01E-12 -1.967 
BACH2  BTB and CNC homology 1, basic leucine zipper transcription factor 2      5.18E-12 -1.989 
FAM171A1  family with sequence similarity 171, member A1 5.47E-12 -1.736 
PRKCA  protein kinase C, alpha  5.47E-12 -1.838 
KIF5C  kinesin family member 5C         8.13E-12 -1.884 
SPON1  spondin 1, extracellular matrix protein  8.77E-12 -2.601 
CCR6  chemokine (C-C motif) receptor 6         9.67E-12 -2.082 
ZNF551  zinc finger protein 551  9.79E-12 -1.932 
MAN1C1  mannosidase, alpha, class 1C, member 1   1.03E-11 -1.870 
ITPKB  inositol 1,4,5-trisphosphate 3-kinase B  1.06E-11 -1.496 
SLC16A10  solute carrier family 16, member 10 (aromatic amino acid transporter)    1.07E-11 -3.204 
SLC4A10  solute carrier family 4, sodium bicarbonate transporter-like, member 10  1.07E-11 -7.548 
PLEKHG4  pleckstrin homology domain containing, family G (with RhoGef domain) 
member 4    
1.17E-11 -1.627 
PPFIBP1  PTPRF interacting protein, binding protein 1 (liprin beta 1)     1.17E-11 -2.289 
EPHA4  EPH receptor A4  1.33E-11 -2.431 
MYC  V-myc myelocytomatosis viral oncogene homolog (avian)    1.59E-11 -2.138 
PLCG1  phospholipase C, gamma 1         1.67E-11 -1.646 
ZNF304  zinc finger protein 304  2.13E-11 -1.579 
AMIGO1  adhesion molecule with Ig-like domain 1  2.75E-11 -1.731 
CDR2  cerebellar degeneration-related protein 2, 62kDa         3.08E-11 -1.534 
DNMT3A  DNA (cytosine-5-)-methyltransferase 3 alpha      3.08E-11 -1.371 
PIK3IP1  phosphoinositide-3-kinase interacting protein 1  3.08E-11 -1.801 
C2orf89  chromosome 2 open reading frame 89 3.14E-11 -1.774 
TMEM63A  transmembrane protein 63A        3.45E-11 -1.523 
LDLRAP1  low density lipoprotein receptor adaptor protein 1 3.52E-11 -1.548 
*p-value is corrected for multiple testing 
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3.2.2 Blood cell-specific genes 
Since whole blood samples were used in this study, differential expression of few genes 
may be attributed to age-related hematopoietic changes. To address this issue, the 
differentially expressed genes that highly correlated with blood cells (r ≥ 0.8) were 
omitted from the further analyses. A study conducted by Palmer et al. (2006) had 
identified gene expression signatures for the major constituent cells of blood, including 
B-cells, CD4+ T-cells, CD8+ T-cells, and granulocytes. This observation was used as a 
basis for categorizing blood cell-specific genes in the present study. However, as no 
validated erythrocyte-specific mRNA transcripts have been described previously, it was 
not possible to filter genes associated with this cell type from the analysis. The only 
study investigating erythrocyte-specific genes worked with erythrocyte cell populations 
of 99.99% purity (Kabanova et al. 2009). Taking into account the extremely low RNA 
content of these anucleate cells, it is likely that a very small proportion of other blood 
cells can influence the results dramatically. Consequently, the resulting data cannot be 
used to precisely identify erythrocyte-specific genes.  
Out of the 6,217 genes that were significantly differentially expressed between long-
lived and young individuals, 139 were blood cell-specific and thus were omitted from 
the further analyses. Of these genes, 112 were downregulated and 27 were upregulated 
in LLI. It was observed that the B-cell and T-cell-specific genes together constituted for 
more than 75% of the identified blood cell-specific genes (Figure 3-1). A list of these 
genes is provided in the supplementary material (Table 8-2). After filtering the 139 
blood cell-specific genes, the remaining 6,078 differentially expressed genes were 
considered for the further analyses. 
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Figure 3-1 Distribution of significant blood cell specific genes (B-cell, T-cell, granulocytes)  
 
3.2.3 Functional grouping of the differentially expressed genes 
The 6,078 genes that were differentially expressed between long-lived and young 
individuals were associated with biological processes in order to place them into a 
biological context. GO analysis (see 2.13) reported that 44 and 75 biological processes 
were significantly represented with respect to the genes upregulated and 
downregulated in LLI, respectively. Among the 75 biological processes associated with 
downregulated genes, 59 were significantly enriched, which means many more genes 
than expected by chance were associated with these processes. On the other hand, 16 
biological processes were significantly depleted – a smaller number of genes than 
expected by chance were associated with these processes. Similarly, out of 44 biological 
processes associated with upregulated genes, 16 were significantly enriched and 28 
were depleted. The top 20 biological processes represented by up- and downregulated 
genes are depicted in Figure 3-2. Interestingly, nine of the top 20 processes were 
metabolism-related and all of them contained more downregulated genes than 
expected by chance, indicating the depletion of these processes in LLI. All the 
significantly represented biological processes are presented in the supplementary 
material (Table 8-3).   
B-cell
T-cell
Granulocytes
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Figure 3-2 The top 20 biological processes (BP) with respect to up- and downregulated genes in 
case of long-lived individuals (LLI) vs. young. Green = significantly enriched processes, red = 
significantly depleted processes, light green = enriched processes but not significant and light 
red= depleted processes but not significant. Interestingly, 9 out of the top 20 were metabolism-
related processes.  
 
3.2.4 Heritable transcriptional activity 
Transcriptomes from the Danish twins were used to estimate the heritability of gene 
expression. The expression levels were determined as described in section 2.6.  Out of 
23,368 genes that were described in the annotation file (hg19), 15,640 were expressed 
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(i.e., log2 FPKM > 0) in more than 95% of the blood samples and were considered for the 
analysis. The heritability of gene expression (transcriptional activity) was estimated by 
employing standard structural equation modeling (biometric modeling) (Neale et al. 
1992). In this study, the narrow-sense heritability (h2), which is the additive genetic 
portion of the phenotypic variance, was assessed for each gene. For this purpose, four 
different models (ACE, AE, CE and E) were fitted for each gene and heritability estimates 
were obtained from the best-fitting model. The best model was chosen based on the 
AIC (Akaike 1974) for non-nested models (AE and CE are non-nested models) and the 
likelihood ratio test for nested models (ACE, AE, CE and E are nested models). Of the 
15,640 genes, the expression of 3,029 genes was identified to be heritable with values 
ranging from 0.30 to 0.99. It was observed that the heritability estimates for around 
55.5% (1,683 of 3,029) of the genes were between 0.4 and 0.6 (Figure 3-4). Interestingly, 
the variation in expression for about 99.9% of the genes with heritable transcriptional 
activity was better explained by the AE model and for two genes (NCAPG2 and ARL17A) 
it was better explained by the ACE model. Furthermore, of the 15,640 genes, the 
variation in expression for around 73.5% of the genes was explained by unique or non-
shared environmental factors, indicating that a large proportion of the genes are 
influenced by non-genetic factors rather than by genetic factors (Figure 3-3). The top 50 
genes with heritable transcriptional activity are provided in the supplementary material 
(Table 8-4) and the remaining genes are provided as an electronic attachment. 
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Figure 3-3 Distribution of genes with respect to different models, namely, ACE, AE, CE and E. (A: 
additive genetic factors, C: common or shared environmental factors, E: unique or non-shared 
environmental factors).  
 
 
 
Figure 3-4 Frequency distribution of heritability estimates derived from gene expression. 
ACE
AE
CE
E
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3.2.5 Functional grouping of the genes with heritable transcriptional activity 
The 3,029 genes with heritable transcriptional activity (see 3.2.4) associated with 693 
biological processes, of which 16 were significantly depleted, and 11 were significantly 
enriched. 
Significantly depleted GO terms included metabolic processes, cell cycle, organelle 
organization and RNA transport. On the other hand, significantly enriched GO terms 
included defense response, cell-cell signaling, cell adhesion, cell communication, 
regulation of hormone levels, reactive nitrogen species metabolic process and 
extracellular structure organization.  
Interestingly, among the 27 significantly represented biological processes, nine were 
metabolism-related (Figure 3-5) and they contained a smaller number of heritable genes 
than expected by chance, illustrating that the genetic contribution to these processes 
plays only a minor role. 
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Figure 3-5 Biological processes (BP) associated with the 3,029 genes with heritable 
transcriptional activity; green= significantly enriched biological processes and red=significantly 
depleted processes.  
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3.3 Genotype data 
In total, 220 samples (73 young and 55 long-lived individuals from Germany and 50 DZ, 
22 MZ and 20 unrelated individuals from Denmark) were genotyped using 
HumanOmniExpress BeadChips (Illumina). Of the 220 samples, six samples (all from 
Denmark, two long-lived DZ and four middle-aged DZ) had a sample call rate below 90% 
and thus were removed from the analysis. Furthermore, SNPs with a minor allele 
frequency below 1%, call rate below 95% and Hardy-Weinberg equilibrium testing p-
value <=0.0001 were excluded from the analysis. After quality control, 636,904 SNPs 
were used for the eQTL analysis for the German samples (73 young and 55 LLI). In the 
case of Danish samples, 621,985 SNPs passed the quality criteria and were employed for 
the eQTL analysis. Since MZ twins are genetically identical, only one individual from 
each pair was genotyped and the same data was used for the other twin. Thus, the eQTL 
analysis was performed with 44 MZ (24 middle-aged and 20 LLI) and 44 DZ twins (24 
middle-aged and 20 LLI). The data from 20 unrelated individuals from Denmark was 
used for validating the cis-eQTL results obtained from the German samples (see 3.5.2).  
Additionally, five variants (two APOE variants: rs429358 and rs7412, which collectively 
define the APOE genotypes and three FOXO3A variants: rs3800231, rs2764264 and 
rs4945816) were genotyped using TaqMan genotyping assays (Life Technologies). These 
variants were genotyped in all of the above mentioned samples, but for four Danish 
unrelated individuals due to the lack of DNA. All of the five variants had a call rate of 
>97% and a minor allele frequency >1%. 
 
3.4 Regulation of gene expression by genetic factors 
To identify eQTLs that have putative cis-regulatory effects on the genes that were 
differentially expressed (see 3.2.1) between long-lived and young individuals, all the 
expression traits were analyzed for association with SNPs that were located in a 1-Mb 
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window (both upstream and downstream from the starting and end points of the gene). 
Similarly, all the expression traits with heritable transcriptional activity (see 3.2.4) were 
analyzed for association with SNPs that were within a 1-Mb window to identify putative 
cis-eQTLs. Additionally, G×A interaction effects were investigated for the differentially 
expressed genes that exhibited significant association with cis-variants. From now on, 
the differentially expressed genes with significant cis-effects are called eQTL genes and 
the differentially expressed genes without significant cis-effects are called non-eQTL 
genes.    
 
3.4.1 Cis-regulation of differentially expressed genes  
Cis-eQTL analysis focusing on SNPs located within a 1-Mb window around each gene 
identified 8,757 statistically significant cis-eQTLs associated with 1,200 genes that were 
differentially expressed between long-lived and young individuals (downregulated in 
LLI=703 genes and upregulated in LLI=497 genes). Of the identified cis-eQTLs, 10.7% 
were located either in an intron or in the untranslated regions (UTRs) of the genes of 
interest. The remaining 89.3% were located either upstream or downstream of the 
genes. Six of the most statistically significant cis-eQTLs identified in the 3’ and 5’ UTRs 
are depicted in Figure 3-8. The cis-eQTLs with the best p-values were strikingly 
concentrated in the close proximity (0.2 Mb) of the genes (Figure 3-6). It was observed 
that about 75.6% (908 genes of 1,200) of the expression traits had more than one 
statistically significant cis-eQTL (Figure 3-7). Furthermore, the cis-eQTLs that influenced 
the same expression trait were in high LD (r2 ≥ 0.5). All the 8,757 statistically significant 
cis-eQTLs are provided as an electronic attachment.  
In order to ensure the quality of the identified cis-eQTLs, around 10% (870 of 8,757) of 
eQTL-hit-SNPs were selected randomly and their genotype cluster plots were subjected 
to visual inspection. Out of the 870 eQTL-hit-SNPs, only 14 SNPs (1.6%) had either 
missing genotypes or overlapping clusters of different genotypes and thus did not pass 
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the visual inspection, which is a statistically negligible proportion and emphasizes the 
good quality of the generated genotype data.   
 
 
Figure 3-6 Spatial distribution of the best cis-eQTLs with best p-values relative to the gene start 
(in the German samples). 
 
 
     
Figure 3-7 Histogram showing the number of cis-eQTLs per gene in the German sample. 
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Figure 3-8 Box plot depiction of the 6 most significant cis-eQTLs identified in the 3’ and 5’ UTR 
regions. Five are 3’ UTR variants and one (ETV7) is a 5’ UTR variant; p-values are corrected for 
multiple testing; x-axis represents the genotypes and y-axis represents the log2 FPKM of the 
gene.  
 
3.4.2 Genotype-age interaction effects on differentially expressed genes 
The eQTL analysis identifies the genetic variants that influence the expression of a gene, 
but it cannot identify a change in the variants’ influence on gene expression due to an 
interaction with age. Therefore, the contribution of the G×A interaction to the variation 
observed in differentially expressed genes was investigated. Of the 6,078 differentially 
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expressed genes, the expression of 1,200 was significantly influenced by cis-eQTLs (see 
3.4.1). Among these 1,200, 908 genes exhibited significant association with more than 
one cis-eQTL. Thus, for each gene, only the cis-eQTLs with the best p-values were 
considered for this analysis. Of the 8,757 cis-eQTLs identified, 2,986 demonstrated the 
most significant cis associations (i.e., the best p-values). G×A interaction analysis 
focusing on these 2,986 cis-eQTLs identified 1,164 G×A interactions associated with 599 
genes. All the identified G×A interactions are provided as an electronic attachment.   
 
3.4.3 Contribution of cis-regulation and G×A interaction to biological 
processes 
GO analysis of the differentially expressed genes identified 107 significant biological 
processes (see 3.2.3). These processes (GO terms) can be broadly classified into three 
categories namely, metabolic processes, immune and defense response, and cell and 
tissue regeneration. The investigation of cis-regulation and G×A interaction effects on 
the differentially expressed genes helped to elucidate the contribution of these factors 
to the biological processes. It was observed that about 20% of the genes involved in 
each of the identified processes were regulated by cis-variants, of which 50% exhibited 
G×A interaction effects. All the significant biological processes identified, and the 
contribution of cis-regulation and G×A interaction effects to each of these processes are 
presented in Table 3-3.  
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Table 3-3 Contribution of cis-regulation and genotype-age interaction effects to biological 
processes. Columns 2-5 categorize the processes into metabolic, immune and defense response, 
cell and tissue regeneration and others; %GeneticContribution indicates the percentage of 
genetic contribution to each of the processes; GA interaction = genotype-age interaction. 
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cellular macromolecule 
metabolic process 
1 0 0 0 1497 0 1239 123 135 0 0 0 17 
regulation of metabolic process 1 0 0 0 1887 0 1554 165 168 0 0 0 18 
macromolecule metabolic 
process 
1 0 0 0 1555 0 1280 128 147 0 0 0 18 
nucleobase-containing 
compound metabolic process 
1 0 0 0 1085 0 890 96 99 0 0 0 18 
cellular aromatic compound 
metabolic process 
1 0 0 0 1105 0 902 101 102 0 0 0 18 
heterocycle metabolic process 1 0 0 0 1101 0 900 99 102 0 0 0 18 
organic cyclic compound 
metabolic process 
1 0 0 0 1125 0 914 105 106 0 0 0 19 
cellular nitrogen compound 
metabolic process 
1 0 0 0 1118 0 915 100 103 0 0 0 18 
regulation of cellular process 0 0 0 1 2728 0 2242 241 245 0 0 0 18 
cellular biosynthetic process 0 0 0 1 918 0 744 84 90 0 0 0 19 
organic substance biosynthetic 
process 
0 0 0 1 938 0 756 86 96 0 0 0 19 
organelle organization 0 0 1 0 509 0 427 49 33 0 0 0 16 
oxidation-reduction process 0 0 0 1 0 185 0 0 0 158 14 13 15 
negative regulation of biological 
process 
0 0 0 1 743 0 616 66 61 0 0 0 17 
protein metabolic process 1 0 0 0 705 0 586 56 63 0 0 0 17 
positive regulation of biological 
process 
0 0 0 1 806 0 651 80 75 0 0 0 19 
RNA transport 0 0 0 1 55 0 48 5 2 0 0 0 13 
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regulation of developmental 
process 
0 0 1 0 139 0 106 15 18 0 0 0 24 
cell-cell signaling 0 0 0 1 0 70 0 0 0 54 6 10 23 
modification of morphology or 
physiology of other organism 
involved in symbiotic interaction 
0 0 0 1 115 0 97 11 7 0 0 0 16 
generation of precursor 
metabolites and energy 
1 0 0 0 0 138 0 0 0 121 10 7 12 
cell communication 0 0 0 1 0 99 0 0 0 79 7 13 20 
modification of morphology or 
physiology of other organism 
0 0 0 1 115 0 97 11 7 0 0 0 16 
small molecule metabolic 
process 
1 0 0 0 0 745 0 0 0 600 77 68 19 
embryonic morphogenesis 0 0 1 0 19 0 14 2 3 0 0 0 26 
immune response-activating 
signal transduction 
0 1 0 0 91 0 81 5 5 0 0 0 11 
interaction with host 0 0 0 1 115 0 98 10 7 0 0 0 15 
embryo development 0 0 1 0 95 0 80 9 6 0 0 0 16 
regulation of signaling 0 0 0 1 686 0 561 61 64 0 0 0 18 
intracellular transport 0 0 0 1 267 0 223 25 19 0 0 0 16 
cellular response to endogenous 
stimulus 
0 0 0 1 249 0 201 25 23 0 0 0 19 
pattern specification process 0 0 0 1 21 0 18 0 3 0 0 0 14 
phosphorus metabolic process 1 0 0 0 352 0 295 33 24 0 0 0 16 
cell cycle 0 0 1 0 162 120 132 17 13 101 11 8 17 
organ morphogenesis 0 0 1 0 23 0 17 4 2 0 0 0 26 
cell-cell adhesion 0 0 0 1 19 0 15 2 2 0 0 0 21 
cell adhesion 0 0 0 1 64 0 48 10 6 0 0 0 25 
cell migration 0 0 0 1 47 0 31 9 7 0 0 0 34 
macromolecule methylation 0 0 0 1 44 0 35 4 5 0 0 0 20 
regulation of response to 
stimulus 
0 0 0 1 845 0 685 77 83 0 0 0 19 
protein transport 0 0 0 1 256 0 212 27 17 0 0 0 17 
ion transport 0 0 0 1 0 120 0 0 0 91 15 14 24 
system process 0 0 0 1 0 129 0 0 0 93 23 13 28 
organic acid metabolic process 1 0 0 0 0 125 0 0 0 92 16 17 26 
single-organism catabolic 
process 
0 0 0 1 0 75 0 0 0 60 8 7 20 
cell cycle process 0 0 1 0 236 0 197 23 16 0 0 0 17 
cellular localization 0 0 1 0 88 0 70 10 8 0 0 0 20 
cellular response to stress 0 1 0 0 259 201 217 22 20 163 15 23 17 
cellular response to chemical 
stimulus 
0 0 0 1 364 0 295 38 31 0 0 0 19 
Golgi vesicle transport 0 0 0 1 57 0 50 5 2 0 0 0 12 
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regulation of cellular component 
organization 
0 0 1 0 312 0 256 29 27 0 0 0 18 
gene silencing 0 0 0 1 26 0 19 4 3 0 0 0 27 
viral process 0 1 0 0 156 0 130 14 12 0 0 0 17 
symbiosis, encompassing 
mutualism through parasitism 
0 1 0 0 156 0 130 14 12 0 0 0 17 
tube morphogenesis 0 0 1 0 1 0 1 0 0 0 0 0 0 
regulation of body fluid levels 0 0 0 1 47 0 37 5 5 0 0 0 21 
cellular developmental process 0 0 1 0 211 0 152 25 34 0 0 0 28 
tissue morphogenesis 0 0 1 0 22 0 19 2 1 0 0 0 14 
antigen processing and 
presentation of exogenous 
antigen 
0 1 0 0 0 44 0 0 0 38 5 1 14 
mitochondrial transport 0 0 0 1 0 31 0 0 0 28 1 2 10 
regulation of cellular component 
biogenesis 
0 0 1 0 100 0 79 12 9 0 0 0 21 
coagulation 0 1 0 0 39 0 30 5 4 0 0 0 23 
organonitrogen compound 
metabolic process 
1 0 0 0 0 199 0 0 0 156 22 21 22 
single-organism biosynthetic 
process 
0 0 0 1 0 47 0 0 0 38 3 6 19 
establishment or maintenance 
of cell polarity 
0 0 1 0 33 0 26 3 4 0 0 0 21 
hematopoietic or lymphoid 
organ development 
0 1 0 0 60 0 49 6 5 0 0 0 18 
maintenance of location in cell 0 0 1 0 34 0 28 4 2 0 0 0 18 
regulation of protein stability 0 0 0 1 38 0 37 0 1 0 0 0 3 
antigen processing and 
presentation of peptide antigen 
0 1 0 0 0 45 0 0 0 38 6 1 16 
system development 0 0 0 1 56 0 39 7 10 0 0 0 30 
regulation of RNA stability 0 0 0 1 19 0 18 0 1 0 0 0 5 
stem cell maintenance 0 0 1 0 33 0 29 1 3 0 0 0 12 
cellular response to abiotic 
stimulus 
0 0 0 1 55 0 45 5 5 0 0 0 18 
digestion 0 0 0 1 0 1 0 0 0 0 1 0 100 
cellular macromolecule 
localization 
0 0 1 0 66 0 52 8 6 0 0 0 21 
cell differentiation 0 0 1 0 147 0 108 17 22 0 0 0 27 
morphogenesis of a branching 
structure 
0 0 1 0 7 0 6 1 0 0 0 0 14 
xenobiotic metabolic process 1 0 0 0 0 13 0 0 0 9 2 2 31 
positive regulation of molecular 
function 
0 0 0 1 253 0 200 24 29 0 0 0 21 
glutathione derivative metabolic 
process 
1 0 0 0 0 11 0 0 0 7 4 0 36 
regionalization 0 0 1 0 13 0 12 0 1 0 0 0 8 
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cellular component movement 0 0 1 0 123 0 94 13 16 0 0 0 24 
regulation of blood pressure 0 0 0 1 0 8 0 0 0 6 1 1 25 
response to other organism 0 1 0 0 0 74 0 0 0 56 11 7 24 
organ development 0 0 1 0 102 0 75 16 11 0 0 0 26 
hydrogen transport 0 0 0 1 0 18 0 0 0 18 0 0 0 
protein localization 0 0 1 0 82 0 63 12 7 0 0 0 23 
immune response-regulating cell 
surface receptor signaling 
pathway involved in 
phagocytosis 
0 1 0 0 25 0 21 3 1 0 0 0 16 
nuclear import 0 0 0 1 27 0 22 3 2 0 0 0 19 
regulation of membrane 
potential 
0 0 0 1 0 19 0 0 0 14 0 5 26 
response to fibroblast growth 
factor stimulus 
0 0 0 1 52 0 43 5 4 0 0 0 17 
activation of innate immune 
response 
0 1 0 0 44 0 41 1 2 0 0 0 7 
synapse organization 0 0 0 1 4 0 2 1 1 0 0 0 50 
extracellular structure 
organization 
0 0 0 1 0 35 0 0 0 26 6 3 26 
defense response to virus 0 1 0 0 0 32 0 0 0 26 4 2 19 
signal transduction 0 0 0 1 448 0 362 36 50 0 0 0 19 
cell death 0 0 0 1 192 0 165 18 9 0 0 0 14 
regulation of immune system 
process 
0 1 0 0 234 0 204 15 15 0 0 0 13 
cellular response to stimulus 0 0 0 1 903 0 739 86 78 0 0 0 18 
endosomal transport 0 0 0 1 42 0 36 4 2 0 0 0 14 
response to virus 0 1 0 0 0 46 0 0 0 38 5 3 17 
cerebral cortex development 0 0 1 0 14 0 8 3 3 0 0 0 43 
viral entry into host cell via 
membrane fusion with the 
plasma membrane 
0 1 0 0 0 3 0 0 0 2 0 1 33 
tube development 0 0 1 0 2 0 2 0 0 0 0 0 0 
cellular catabolic process 0 0 0 1 0 220 0 0 0 178 23 19 19 
regulation of localization 0 0 0 1 308 0 253 31 24 0 0 0 18 
regulation of multicellular 
organismal process 
0 0 0 1 228 0 174 29 25 0 0 0 24 
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3.4.4 Cis-regulation of genes with heritable transcriptional activity 
Cis-eQTL analysis was performed for all the 3,029 genes with heritable transcriptional 
activity. Of these genes, 1,248 exhibited a statistically significant association with 18,066 
cis-eQTLs (see electronic attachment). Around 85% of the cis-regulated genes exhibited 
association with multiple cis-eQTLs (Figure 3-9). Furthermore, the cis-eQTLs with the 
most significant associations were concentrated in the close proximity (0.2 Mb) of the 
genes (Figure 3-10). The investigation of the proportion of cis-eQTLs in different 
heritability categories (h2=0.3-0.39, 0.4-0.49, 0.5-0.59 and ≥0.6) showed that the genes 
with higher heritability estimates (h2 ≥ 0.6) associated with a larger proportion of cis-
eQTLs. About 60.4% of the identified cis-eQTLs associated with the genes that had 
heritability estimates ≥0.6 (Figure 3-11).   
The quality of these cis-eQTLs was examined by visually inspecting the genotype cluster 
plots of 10% (1,806 of 18,066) of eQTL-hit-SNPs. Out of the 1,806 eQTL-hit-SNPs, the 
cluster plots of only 40 SNPs (2.2%) did not pass the visual inspection i.e., had either 
missing genotypes or overlapping clusters of different genotypes. 
 
     
Figure 3-9 Histogram showing the number of eQTLs per gene in the Danish sample.  
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Figure 3-10 Spatial distribution of the best cis-eQTLs relative to the gene start position (in the 
Danish sample). 
 
 
    
  Figure 3-11 Proportion of cis-eQTLs in different heritability categories. 
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3.4.5 Cis-regulatory effects of known age-associated variants 
The APOE genotypes that are determined from rs429358 and rs7412 as well as the 
FOXO3A variants namely, rs3800231, rs2764264 and rs4945816 have been repeatedly 
associated with longevity (Flachsbart et al. 2009; Lindahl-Jacobsen et al. 2013). Hence, 
the effect of these variants on their respective mRNA levels was investigated in the 
German as well as in the Danish sample. The eQTL analysis revealed that there is no 
significant cis association between these variants and the corresponding mRNA levels. 
 
3.5 Biological validation using the Danish samples 
In order to validate the findings from the differential expression analysis and the cis-
eQTL analysis (from the German sample), the Danish samples were used. Since the 
Danish dataset consisted of twins, the validation set was created by selecting one 
individual from each twin pair (see 2.14). Additionally, 10 unrelated cases (83–92 years) 
and 10 unrelated controls (58–60 years) from Denmark were included in the validation 
set. Therefore, in total, 34 cases and 34 controls were employed for this analysis. 
 
3.5.1 Differential expression analysis 
Transcriptomes from the 68 Danish samples (cases=34 [83–92 years], controls=34 [58–
60 years]) were used to investigate the 6,078 genes that were found to be differentially 
expressed in the German sample. Out of the 6,078 genes, 5,183 were regulated in the 
same direction as in the German dataset (i.e., exhibited the same trend), while 1,661 
showed a Benjamini – Hochberg corrected p-value ≤ 0.05 and a FDR ≤ 5% (see electronic 
attachment). However, when the same cutoff criteria (Benjamini – Hochberg corrected 
p-value ≤ 0.001 and a FDR ≤ 0.1%) as in the German study were applied to the Danish 
Results                                             
57 
 
validation set, only 317 genes of the 6,078 were identified as differentially expressed 
and these genes showed the same trend as in the German dataset.  
Since the validation dataset was smaller than the German sample, the genes with p-
value ≤ 0.05 were considered for the subsequent gene ontology analysis. Interestingly, 
among the top 25 significantly represented biological processes, nine were metabolism-
related and contained more downregulated genes than expected by chance as observed 
in the German sample. All the significantly represented processes are presented in the 
supplementary material (Table 8-5). 
   
3.5.2 Expression quantitative trait loci analysis 
Transcriptome and genotype data from the 68 Danish samples were used to validate the 
results obtained from the cis-eQTL analysis that was performed with the German 
dataset. Of the 68 samples, genotype data from four samples (two controls and two 
cases) had a sample call rate below 90% and were excluded from the analysis. 
Therefore, 32 cases (83–92 years) and 32 controls (58–60 years) were used for this 
analysis. Additionally, SNPs with a minor allele frequency ≤ 1%, call rate ≤ 95% and 
Hardy-Weinberg equilibrium testing p-value <=0.0001 were omitted. In total, 618,263 
SNPs passed the quality criteria and were employed for the eQTL analysis.  
Of the 1,200 genes which exhibited a significant association with cis-variants in the 
German sample, 374 genes exhibited significant cis association in the Danish dataset as 
well. Cis-eQTL analysis detected 3,332 statistically significant cis-eQTLs associated with 
these 374 genes. However, out of the 3,332 cis-eQTL signals, 2,017 were unique to this 
dataset. As observed in the German sample, the cis-eQTLs with the best p-values were 
concentrated in the close proximity (0.2 Mb) of the genes (Figure 3-12). All the cis-eQTLs 
identified in the Danish dataset are provided as an electronic attachment. 
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As previously described for the German sample and the Danish twins, the genotype 
cluster plots of 10% (333 of 3,332) of eQTL-hit-SNPs were subjected to visual inspection. 
Among the 333 eQTL-hit-SNPs, only 8 (2.4%) failed the visual inspection. 
 
 
Figure 3-12 Spatial distribution of the best cis-eQTLs relative to the gene start position (in the 
Danish validation set). 
 
3.6 Technical replication of selected genes by real-time qPCR 
To replicate the results from the transcriptome sequencing, the expression levels of 
selected genes were measured by RT-qPCR in the German dataset. Since five samples 
(three young and two LLI) lacked RNA, the remaining 70 young individuals [20–55 years] 
and 53 LLI [91–102 years] were used for this analysis. Eighty genes (Table 3-5) were 
selected based on their ranks with respect to effect size (fold change), significance in the 
analysis between long-lived and young individuals, and regulation of their expression by 
cis-eQTLs. Additionally three control groups were selected, including (a) four 
endogenous control genes (Table 2-3); (b) five genes with no or low variation in 
expression levels among the samples (Table 3-4); and (c) five genes which are known or 
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presumed to have a genetic association with longevity, but were not differentially 
expressed between long-lived and young individuals (Table 2-3). Of these three control 
groups, three genes (RER1, E2F4 and BFAR) from group (b) showed minimum variation 
in the expression levels across the samples and, therefore, the median of their 
expression levels was used to normalize the expression of the 80 candidate genes. Out 
of the 80, the signals of six genes turned out to be undetermined and therefore were 
not included in the analysis. From the remaining 74 genes, 50 were significantly 
differentially expressed between long-lived and young individuals (Benjamini – 
Hochberg corrected p-value ≤ 0.05; FDR ≤ 5%) and showed the same trend as in the 
transcriptome sequencing data (see supplementary material Table 8-6). Furthermore, 
permutation analysis revealed that, by chance, only 0.042 of the 74 genes could be 
expected to be differentially expressed. However, finding 50 genes as differentially 
expressed is more than expected by chance (Fisher’s exact test p-value= 7.57 × 10-17). 
The average correlation coefficient (between RNA-sequencing and RT-qPCR data) for the 
top 10 differentially expressed genes was 0.81, indicating that the transcriptome 
sequencing results were highly correlated with the RT-qPCR values. Figure 3-13 shows 
the correlation plot for one of the genes (ETV7).  
 
Table 3-4 Five genes with no or low variation in expression levels in the German sample. 
Gene symbol Gene name TaqMan assay ID 
RER1 RER1 retention in endoplasmic reticulum 1 homolog (S. 
cerevisiae) 
Hs00199824_m1 
SENP5 SUMO1/sentrin specific peptidase 5 Hs00381410_m1 
PRPF3 pre-mRNA processing factor 3 Hs00757030_m1 
E2F4 E2F transcription factor 4, p107/p130-binding Hs00608098_m1 
BFAR bifunctional apoptosis regulator Hs00275423_m1 
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Figure 3-13 Correlation of expression levels between RNA-seq and TaqMan for the gene ETV7. 
Pink=young individuals, green=long-lived individuals.  
 
Table 3-5 List of 80 candidate genes and their TaqMan assays used for validation. 
Gene symbol Gene name TaqMan assay ID 
APOL4 apolipoprotein L, 4 Hs00540930_m1 
ETV7 ets variant 7 Hs00903229_m1 
C1QC complement component 1, q subcomponent, C chain Hs00757779_m1 
C8G complement component 8, gamma polypeptide Hs00167188_m1 
HP haptoglobin Hs00605928_g1 
NGFR nerve growth factor receptor Hs00609977_m1 
SMTNL1 smoothelin-like 1 Hs00418171_m1 
MMP23B matrix metallopeptidase 23B Hs04187882_g1 
IFNG interferon, gamma Hs00989291_m1 
SEPT4 septin 4 Hs00910208_g1 
SATB2 SATB homeobox 2 Hs00392652_m1 
FZD4 frizzled family receptor 4 Hs00201853_m1 
ASGR2 asialoglycoprotein receptor 2 Hs00154160_m1 
RNASE3 ribonuclease, RNase A family, 3 Hs01923184_s1 
MDK midkine (neurite growth-promoting factor 2) Hs00171064_m1 
DDB2 damage-specific DNA binding protein 2, 48kDa Hs03044953_m1 
BLVRA biliverdin reductase A Hs00167599_m1 
TCN1 transcobalamin I (vitamin B12 binding protein, R binder family) Hs01055542_m1 
Results                                             
61 
 
Gene symbol Gene name TaqMan assay ID 
SPHK1 sphingosine kinase 1 Hs00184211_m1 
LMCD1 LIM and cysteine-rich domains 1 Hs00205871_m1 
LAP3 leucine aminopeptidase 3 Hs00429769_m1 
C1QA complement component 1, q subcomponent, A chain Hs00706358_s1 
IGFBP2 insulin-like growth factor binding protein 2, 36kDa Hs01040719_m1 
CLEC3B C-type lectin domain family 3, member B Hs00162844_m1 
SARNP SAP domain containing ribonucleoprotein Hs00793492_m1 
PRTN3 proteinase 3 Hs01597752_m1 
NAALADL1 N-acetylated alpha-linked acidic dipeptidase-like 1 Hs00193839_m1 
AMH anti-Mullerian hormone Hs00174915_m1 
CTSL cathepsin L Hs00377632_m1 
ZSCAN9 zinc finger and SCAN domain containing 9 Hs00196838_m1 
PRSS23 protease, serine, 23 Hs00359912_m1 
NT5C3B 5'-nucleotidase, cytosolic IIIB Hs00369454_m1 
MARCO macrophage receptor with collagenous structure Hs00198935_m1 
CCL23 chemokine (C-C motif) ligand 23 Hs00270756_m1 
CXCL10 chemokine (C-X-C motif) ligand 10 Hs01124251_g1 
TBKBP1 TBK1 binding protein 1 Hs00207037_m1 
CTSK cathepsin K Hs00166156_m1 
CTSG cathepsin G Hs00175195_m1 
LXN latexin Hs00220138_m1 
ELF3 E74-like factor 3 (ets domain transcription factor, epithelial-
specific ) 
Hs00963881_m1 
FEZ1 fasciculation and elongation protein zeta 1 (zygin I) Hs00192714_m1 
SFRP5 secreted frizzled-related protein 5 Hs00169366_m1 
BATF2 basic leucine zipper transcription factor, ATF-like 2 Hs00293780_m1 
ETS1 v-ets avian erythroblastosis virus E26 oncogene homolog 1 Hs00428293_m1 
SATB1 SATB homeobox 1 Hs00161515_m1 
SPTBN1 spectrin, beta, non-erythrocytic 1 Hs00162271_m1 
GZMH granzyme H (cathepsin G-like 2, protein h-CCPX) Hs00277212_m1 
PLAG1 pleiomorphic adenoma gene 1 Hs00231236_m1 
ZNF229 zinc finger protein 229 Hs00970997_m1 
HIVEP2 human immunodeficiency virus type I enhancer binding protein 2 Hs00198801_m1 
AXIN2 axin 2 Hs00610344_m1 
LRRN3 leucine rich repeat neuronal 3 Hs01087516_m1 
ZNF154 zinc finger protein 154 Hs01068902_m1 
ZNF135 zinc finger protein 135 Hs00987427_g1 
TSPYL5 TSPY-like 5 Hs00603217_s1 
PRKCA protein kinase C, alpha Hs00925193_m1 
MAN1C1 mannosidase, alpha, class 1C, member 1 Hs00220595_m1 
PDGFRB platelet-derived growth factor receptor, beta polypeptide Hs01019589_m1 
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Gene symbol Gene name TaqMan assay ID 
ZNF551 zinc finger protein 551 Hs00292939_m1 
ANK3 ankyrin 3, node of Ranvier (ankyrin G) Hs00253210_m1 
SERPINB10 serpin peptidase inhibitor, clade B (ovalbumin), member 10 Hs00192370_m1 
RAPGEF3 Rap guanine nucleotide exchange factor (GEF) 3 Hs00183449_m1 
RNASE4 ribonuclease, RNase A family, 4 Hs00377763_m1 
DYNLT1 dynein, light chain, Tctex-type 1 Hs00831821_s1 
MAPK8IP1 mitogen-activated protein kinase 8 interacting protein 1 Hs00271363_m1 
ELANE elastase, neutrophil expressed Hs00975994_g1 
CYB5R2 cytochrome b5 reductase 2 Hs00212055_m1 
CAPG capping protein (actin filament), gelsolin-like Hs00156249_m1 
GSTM4 glutathione S-transferase mu 4 Hs00426432_m1 
NUDT18 nudix (nucleoside diphosphate linked moiety X)-type motif 18 Hs00368715_m1 
CCL4 chemokine (C-C motif) ligand 4 Hs00237011_m1 
NRG1 neuregulin 1 Hs00247620_m1 
PLA2G16 phospholipase A2, group XVI Hs00912734_m1 
ATF3 activating transcription factor 3 Hs00231069_m1 
NR1H3 nuclear receptor subfamily 1, group H, member 3 Hs00172885_m1 
ARG1 arginase 1 Hs00968979_m1 
PPP1R3G protein phosphatase 1, regulatory subunit 3G Hs03805942_s1 
FAM109B family with sequence similarity 109, member B Hs03025388_s1 
MDP1 magnesium-dependent phosphatase 1 Hs04194678_s1 
HOXB7 homeobox B7 Hs00270131_m1 
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4 Discussion 
The objective of this study was to identify the transcriptome patterns that are 
associated with the complex phenotype of human longevity and investigate the effects 
of genetic variation on those patterns. Comparing the RNA-sequencing-based 
transcriptome profiles (from blood) of LLI with those of young controls revealed 
thousands of genes that were differentially expressed. This data was subsequently 
integrated with genotype information from the same individuals, resulting in the 
identification of several genes that are regulated by cis-variants. About 50% of the cis-
regulated genes exhibited a G×A interaction, illustrating that the genetic influence on 
mRNA expression changes with age. Additionally, a heritability analysis employing 
monozygotic (MZ) and dizygotic (DZ) twins identified thousands of genes with heritable 
transcriptional activity. To place the differentially expressed genes, cis-regulated genes 
and genes with heritable transcriptional activity in a biological context, a GO analysis 
was performed. It highlighted three broad functional categories, namely metabolic 
processes, immune and defense responses and cell and tissue regeneration.     
    
4.1 Adaptation of the eQTL study design for longevity research 
Human longevity is a complex phenotype that is influenced by both genetic and 
environmental factors, including gene-environment interactions (Tan et al. 2002). 
Moreover, in contrast to most complex diseases, human longevity is a very 
heterogeneous phenotype. Genetic approaches in longevity research have thus far 
provided very limited insights into the determinants and mechanisms underlying 
longevity. Therefore, researchers have focused on alternative methods to identify 
longevity-associated genes and the biological processes functionally linked to these 
genes. One such approach has been to perform transcriptome studies (Rodwell et al. 
2004; Zahn et al. 2006; Hong et al. 2008; Harries et al. 2011; Passtoors et al. 2012; 
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Marttila et al. 2013). A majority of transcriptome studies in longevity research use cross-
sectional designs. Using these designs, it is not possible to distinguish between changes 
in gene expression that cause or are consequences of longevity. 
 Natural genetic variation affects mRNA expression levels and thereby impacts 
molecular and physiological phenotypes (Ackermann et al. 2013). Since DNA variants do 
not change over time for a given individual, integrating genotype information with gene 
expression data can help to explain the age-associated variation in gene expression. 
Therefore, in the present study, an eQTL analysis was employed to investigate the 
association between genetic variants and mRNA expression levels. Considering the 
above-mentioned limitations of a cross-sectional study design, this approach provides 
an opportunity to determine the primary (genetic) basis of gene regulation and to gain 
insight into otherwise unknown genotype-phenotype correlations.  
     
4.2 Differentially expressed genes in blood between long-lived 
individuals and young controls 
In this thesis, RNA-sequencing-based transcriptome profiling was employed to 
investigate differentially expressed genes between long-lived and young individuals. 
Contrary to previous transcriptomic studies using blood samples, a large number of 
genes were found to be differentially expressed between the two groups. Out of 19,991 
genes that were expressed in more than 5% of the German sample, 6,078 (~30%) were 
significantly differentially expressed after filtering for blood cell-specific genes. Among 
these differentially expressed genes, 44% were upregulated and 56% were 
downregulated in LLI. This observed imbalance between up- and downregulated genes 
is consistent with previous longevity studies (Tan et al. 2008; Harries et al. 2011; 
Passtoors et al. 2012). Additionally, the expression levels of 178 genes exhibited a 
statistically significant gender effect. Interestingly, of the 178 genes, 17 were X-linked, 
which was significantly more than expected by chance (p-value = 0.00038). Moreover, 
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these X-linked genes showed the most significant gender effect, in agreement with 
previous findings (Tan et al. 2008). 
Previous blood transcriptome studies in longevity research have identified very few 
genes (around 2–7%) associated with age (Harries et al. 2011; Passtoors et al. 2012). All 
previous transcriptome studies in the field of longevity have employed microarray 
technology. Here, using an RNA-sequencing-based approach yielded a substantially 
larger proportion of differentially expressed genes (~30%). This large proportion can be 
attributed to the ability of RNA-seq to quantify highly abundant as well as rare 
transcripts (i.e., high dynamic range) and to the large number of individuals included in 
this study. The power to detect significantly differentially expressed genes increases 1) 
with the accuracy and dynamic range of a measuring method and 2) with the sample 
size (here, 128 individuals). Identifying a higher number of differentially expressed genes 
using RNA-seq in comparison to microarrays is in line with the literature (Marioni et al. 
2008; Su et al. 2011).     
The most statistically significant differentially expressed gene was leucine-rich repeat 
neuronal 3 (LRRN3), which showed a 9.1-fold decreased expression in LLI at a 
significance level of p=9.03 × 10-17. LRRN3 is involved in the activation of MAPK activity 
and endocytosis and, interestingly, it has been observed as the top candidate in several 
other longevity studies (Hong et al. 2008; Harries et al. 2011; Passtoors et al. 2012). 
Similarly, other genes such as endosialin  (CD248), NEL-like 2 (NELL2), actin binding LIM 
protein 1 (ABLIM1), myobrevin (VAMP5) and chemokine (C-C motif) receptor 7 (CCR7) 
identified as top candidates in this study were also reported by other researchers 
(Harries et al. 2011; Passtoors et al. 2012). This concordance may serve as proof-of-
principle and confirms the validity of the approach employed in the present study. This 
might also indicate that, in contrast to genetic association findings, observations on a 
functional level have a higher validation rate and thus are more commonly shared 
between different study populations. 
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In the present study, the mechanistic target of rapamycin (MTOR) gene, which encodes 
a serine/threonine kinase, was downregulated in LLI compared to young individuals. The 
downregulation of MTOR is associated with lifespan extension in model organisms and 
its increased activity in humans has been associated with a spectrum of cancers (Guertin 
and Sabatini 2005). Additionally, the v-myc avian myelocytomatosis viral oncogene 
homolog (MYC), which encodes the transcription factor MYC, was downregulated in LLI. 
Approximately 50% of human cancers exhibit overexpression of MYC, which is 
negatively correlated with patient survival (Tansey 2014). The genes MTOR and MYC 
were reported to be downregulated in LLI in previous studies as well (Passtoors et al. 
2012). Taken together, the observed downregulation of MTOR might indicate a lower 
cancer risk, yet this lower mRNA expression was not associated with particular genetic 
variants in the present study.  
Many other factors are known to influence human longevity, including alterations to 
nutrient-sensing pathways such as TOR or IIS. A recent study investigated the expression 
of 40 genes that belong to the well-described core of the mTOR pathway and reported 
that seven were differentially expressed between LLI and control individuals (Passtoors 
et al. 2013). Five of these seven genes were found to be differentially expressed 
(Benjamini–Hochberg corrected p-value ≤ 0.001; FDR ≤ 0.1%) in the present study as 
well. This concordance further supports the validity of the approach chosen here. 
Finally, the identification of a large number of differentially expressed genes emphasizes 
the notion that longevity is a complex phenotype influenced by many genes and 
biological processes.  
 
4.3 Age-associated gene regulation influenced by cis-variants 
The eQTL analysis was used in this study to determine the genetic basis of age-
associated gene regulation. Of all the 6,078 differentially expressed genes, 19.74% 
(1,200 of 6,078) had at least one significant cis-eQTL. In line with previous eQTL studies, 
Discussion                                             
67 
 
genetic variation with strong impact on gene expression were predominantly found in 
close proximity to transcription start sites (Innocenti et al. 2011; Stranger et al. 2012; 
Bryois et al. 2014). Furthermore, many expression traits were associated with multiple 
cis-eQTLs and cis-eQTLs associated with the same expression trait were in high LD (r2 ≥ 
0.5) as previously reported (Kabakchiev and Silverberg 2013). Taking into account that 
genes under genetic control were influenced by seven variants on average in the 
German sample, these findings further support the hypothesis of a complex underlying 
molecular pattern, where different variants may lead to the same phenotype. 
Although eQTL analyses are a common approach to identify variants that influence gene 
expression, they do not reveal if the regulation of gene expression changes with age. 
Therefore, investigating G×A interactions can provide further insight into the effect of 
age on the influence of genetic variation on mRNA levels. More than 400 G×A 
interactions have previously been reported in human skin and adipose tissues (Glass et 
al. 2013) and more than 600 have been reported in blood (Kent et al. 2012). In the 
present study, when focusing only on the most significant cis-eQTLs for each gene, it 
was observed that 9.9% of the differentially expressed genes (368 that were 
downregulated and 231 that were upregulated in LLI) exhibited a G×A interaction. This is 
in agreement with a previous longevity study performed in blood which reported that 
13.94% of the differentially expressed genes showed G×A interactions (Kent et al. 2012). 
Interestingly, the most highly differentially expressed gene, LRRN3 did not exhibit a G×A 
interaction in this study, but it was found to have a significant G×A interaction by Kent 
et al. (2012). In addition, the UBQLNL gene, whose expression and cis genotype are 
associated with a longitudinal cancer risk and display a G×A interaction (Kent et al. 
2012), was not differentially expressed in the present study. These discrepancies may be 
due to the sample-specific differences, especially the different age ranges of individuals 
included in the two studies.  
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Overall, age-associated genes were partially influenced by genetic factors and the 
observation of G×A interaction effects on gene expression indicates that the impact of 
genetic variants on mRNA expression changes with age. However, the cross-sectional 
study design used here does not allow to address if the observed G×A interaction effects 
on mRNA expression are a life-long phenomenon or does it occur only at advanced age.   
 
4.4 Influence of known APOE and FOXO3A variants on gene expression 
in blood 
Several genetic studies have been performed to identify the determinants that influence 
the complex longevity phenotype. Although many putative loci associated with longevity 
have been reported, variations in only two genes have been consistently replicated thus 
far. These two genes are APOE (Schächter et al. 1994; Zhang et al. 1998; Blanché et al. 
2001) and FOXO3A (Willcox et al. 2008; Flachsbart et al. 2009; Li et al. 2009). APOE is 
known to play an important role in regulating lipoproteins (Smith 2002; Christensen et 
al. 2006) whereas FOXO3A encodes the evolutionarily conserved transcription factor 
forkhead box protein O 3A (FOXO3A), a homolog of daf-16 in C. elegans. It is well 
described that the transcription factor encoded by daf-16 functions as a key regulator in 
the IIS pathway and influences metabolism and lifespan in model organisms (Ogg et al. 
1997; Giannakou et al. 2004). 
Although variations in APOE and FOXO3A have been consistently associated with 
longevity, the influence of these variants on mRNA levels remains to be elucidated. In 
this study, two APOE (rs429358 and rs7412) and three FOXO3A (rs3800231, rs2764264 
and rs4945816) genotypes that are associated with longevity were investigated to 
evaluate their effects on APOE and FOXO3A expression, respectively. The results 
indicated that these genotypes have no significant effect on their respective gene 
expression in blood. It is not known whether these genotypes influence the gene 
expression in other tissues. The major sites for APOE expression are liver and brain 
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(Elshourbagy et al. 1985), whereas FOXO3A is expressed in the major insulin responsive 
tissues such as liver, adipocytes and skeletal muscle (Banasik et al. 2011). The genotype-
dependent expression in the relevant tissues remains to be examined. Considering that 
the current study analyzed cis-associations only, it is likely that the APOE and FOXO3A 
variants may influence transcripts located in trans. Identifying such trans-interactions, 
however, is a challenging task, as the power to detect such effects requires substantially 
larger sample numbers.     
 
4.5 Large proportion of age-associated genes are regulated 
independent of cis-variants 
In this study, thousands of genes were identified as differentially expressed between 
long-lived and young individuals. Of the differentially expressed genes, only 19.74% 
were identified to be significantly regulated by cis-variants and only 9.9% were 
identified to exhibit G×A interaction. In contrast, more than 80% of the differentially 
expressed genes did not exhibit significant association with cis-variants. It is likely that 
the expression of these genes is influenced by trans-variants or possibly by 
environmental factors, which were not investigated in this thesis. The impact of non-
genetic factors is supported by the heritability analysis performed in this study that has 
revealed that the variation in gene expression for a large proportion of genes can be 
explained by environmental rather than by genetic factors. The individual contribution 
of genetic and non-genetic factors remains unclear unless trans-interactions have been 
investigated in detail. Finally, assessing the nature and contribution of non-genetic 
factors to human longevity may be one of the most challenging tasks in this research 
field, as it is next to impossible to perform longitudinal studies with human subjects in 
controlled environments. 
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4.6 Transcriptional activity as a heritable trait 
Phenotypic variation among individuals, such as differences in gene expression, is a 
natural phenomenon that occurs in normal conditions or can be caused by disease 
states. Several studies indicate that a considerable proportion of variation in gene 
expression can be attributed to genetic factors, and therefore, is heritable (Schadt et al. 
2003; Cheung et al. 2003; Tan et al. 2005). In addition to genome-wide significant eQTLs, 
which are considered heritable, other polygenic variation may exist that fails to reach 
statistical significance by normal genotype-expression association analysis. The classical 
twin design, comparing resemblance in MZ and DZ twin pairs, provides distinct 
advantages in the efficiency of heritability estimation (van Dongen et al. 2012; Wright et 
al. 2014). In the present study, the gene expression profiles of 96 twins (44 MZ and 52 
DZ) were examined employing structural equation modeling to quantify the heritability 
of gene expression in blood. Analysis of 15,640 genes expressed in at least 95% of the 
samples facilitated to estimate the extent to which genetic factors contribute to the 
variation in gene expression.  
The analysis demonstrated that there was a significant genetic component underlying 
the regulation of gene expression in blood. The expression levels of 19.36% (3,029 of 
15,640) of genes were under significant genetic control. This is in contrast to a recent 
publication that reported a proportion of heritable genes of 4.2% (777 of 18,392) in 
blood (Wright et al. 2014). However, a study performed with human lymphocytes has 
reported a much higher proportion (85%) of transcripts under genetic control (Göring et 
al. 2007). This variability in the proportion of genes exhibiting heritable expression 
demonstrates that gene expression levels should be considered with caution when used 
as traits because an expression profile is a snapshot of the cellular state and is tissue-
specific. The extent of genetic control (estimated as narrow-sense heritability) on 
individual genes in the current study ranged from h2 = 0.30 to h2 = 0.99. Though 19.36% 
of the genes were under significant genetic regulatory control, only 6.2% of genes had 
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considerably high expression heritability estimates (h2 ≥ 0.6). Since the analysis was 
performed with corrections for age and gender, it indicates that non-genetic factors 
influence the expression of the majority of genes. 
The 3,029 genes identified as being under significant genetic control were further 
subjected to eQTL analysis to identify cis-eQTLs that have significant influence on 
expression. It was observed that 1,248 genes had at least one significant eQTL after 
correcting for multiple testing (Benjamini and Hochberg’s method, FDR ≤ 5%). When 
investigating the proportion of cis-eQTLs in different heritability categories, it was 
revealed that the genes with high heritability estimates (h2 ≥ 0.6) were likely to have a 
larger proportion of cis-eQTLS than genes with low heritability estimates. Furthermore, 
the genes with at least one significant cis-eQTL had significantly higher heritability (P-
value = 2.6 × 10-15), which is in concordance with previous studies (Wright et al. 2014). 
Taken together, the heritability of gene expression and the proportion of cis-eQTLs 
associated with heritable genes illustrate the role of genetic control in biological 
processes.   
   
4.7 Prominent depletion of metabolic processes in long-lived 
individuals 
The relationship between metabolism and longevity has been a topic of interest for 
more than a century. In 1908, the German Physiologist Max Rubner discovered a 
relationship between longevity, metabolic rate and body size. He described that larger 
animals live longer and have slower metabolic rates than smaller animals. Thus, he 
proposed that longevity is inversely proportional to metabolic rate (Rubner 1908). 
Subsequently, the American biologist Raymond Pearl expanded Rubner’s work and 
proposed the “rate-of-living” hypothesis, which suggests a direct link between 
metabolic output and longevity in eukaryotes (Pearl 1928). Three decades later, 
Denham Harman formulated the widely accepted oxidative damage model (Harman 
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1956). This model proposes that reactive oxygen species (ROS) are produced during 
normal metabolism, and they subsequently damage important biological molecules 
(DNA, proteins and lipids), and eventually cause senescence. It has been suggested that 
an increased metabolic rate promotes increased production of ROS and thus accelerates 
senescence (Beckman and Ames 1998). In this context, caloric restriction is claimed to 
extend lifespan by reducing metabolic rate, and therefore ROS production rate 
(Braeckman et al. 2006). However, in 2004, the mathematician and biologist Lloyd 
Demetrius suggested that the most important factor involved in lifespan is not 
metabolic rate or oxidative stress, but metabolic stability, which is the capacity of an 
organism to maintain steady state concentration of metabolites. He proposed that 
caloric restriction prolongs lifespan by increasing metabolic stability (Demetrius 2004).  
Based on these theories, several studies have been performed in model organisms as 
well as in humans to elucidate the link between metabolism and longevity. Interestingly, 
an inverse relationship between metabolism and longevity has not been observed in 
populations of Drosophila melanogaster with different lifespans (van Voorhies et al. 
2003; Khazaeli et al. 2005). In C. elegans, though reduced metabolic rates have been 
observed in several long-lived mutants (daf-2 and age-1 mutants) (Van Voorhies and 
Ward 1999; Van Raamsdonk et al. 2010; Lee et al. 2012;), there have been contradictory 
results as well (Braeckman et al. 2002). In humans, it has been reported that a high 
metabolic rate is a risk factor for natural mortality (Ruggiero et al. 2008; Jumpertz et al. 
2011). Furthermore, individuals (40–96 years) who are fully functional and free of major 
medical conditions have significantly lower resting metabolic rates than those with 
disease and functional impairments (Schrack et al. 2014). As mitochondria are 
semiautonomous organelles producing most of the ROS and metabolic rate is a 
mitochondrial-associated parameter (Lehmann et al. 2008), researchers have 
investigated the relative amount of mitochondrial DNA (mtDNA) in LLI. A study by Van 
Leeuwen et al. (2014) demonstrated that LLI exhibit lower mtDNA content than their 
offspring. Furthermore, the offspring of LLI also have reduced mtDNA content compared 
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to their partners. These results may indicate that I) metabolic rate as an inherited trait 
impacts longevity or II) reduced mtDNA serves as an indicator of a passive lifestyle (e.g., 
reduced physical activity and moderate food intake). However, these findings still need 
to be replicated. Taken together, the results of these studies do not clarify whether a 
reduced metabolic rate predisposes individuals to longevity or is a consequence of 
advanced age. 
 In this study, though metabolic rates were not measured, a prominent depletion of 
metabolic processes in LLI was observed on the transcriptome level. The GO analysis of 
differentially expressed genes revealed that this depletion in several metabolism-related 
processes was the result of the downregulation of a large number of metabolism-
associated genes. This number was considerably higher than expected by chance, 
implying a significant depletion of metabolic processes in LLI.  
As described in section 1.3.1, there is substantial evidence from model organisms that 
the reduced activity of the IIS pathway not only causes an increase in lifespan but also 
induces metabolic changes (Kimura et al. 1997). In this study, genes involved in the IIS 
pathway such as insulin-like growth factor 1 receptor (IGF1R), insulin-like growth factor 
2 receptor (IGF2R), phosphatidylinositol-3-phosphate 5-kinase (PIP5K3/PIKFYVE), 
phosphoinositide 3-kinase regulatory subunit 4 (PIK3R4), protein kinase C, alpha 
(PRKCA), protein kinase A catalytic subunit beta (PRKACB) and interaction protein for 
cytohesin exchange factors 1 (IPCEF1) were downregulated in LLI, in concordance with a 
previous study (Abdul Rahman et al. 2013). The key transcription factor of the IIS 
pathway, FOXO3A, which is one of the homologues of daf-16 in C. elegans, was not 
differentially regulated between LLI and young controls. However, another homologue 
of daf-16, forkhead box O1 (FOXO1), which plays a significant role in regulating whole 
body energy metabolism (Gross et al. 2008), was downregulated in LLI. These 
observations further support the link between longevity and low metabolic rate (Rubner 
1908) and indicate that depletion of metabolism may be associated with longevity. A GO 
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analysis based on transcriptome data generally only shows an association between a 
phenotype and a molecular profile. In contrast, the eQTL approach used here revealed 
that the depletion of metabolic processes is at least a partially causative factor 
underlying the longevity phenotype. Consequently, this study presents molecular data 
supporting a potentially causative link between metabolism and longevity in humans on 
the transcriptome level.   
       
4.8 Remodeling of immune and defense responses in long-lived 
individuals 
A popular concept among researchers is that advanced age is associated with 
deterioration of the immune system. However, Franceschi et al. (1995) proposed that 
most immune parameters undergo a continuous remodeling with age, where some 
parameters increase, some decrease and others remain unchanged, rather than a 
unidirectional deterioration. In this study, among the immune related genes that were 
differentially expressed, several were upregulated and several others were 
downregulated in LLI. The genes, such as chemokine (C-C motif) receptor 7 (CCR7), 
chemokine (C-C motif) receptor 6 (CCR6), CD27 molecule (CD27), lymphotoxin-beta 
(LTB) and endosialin (CD248) were downregulated in LLI, which is in agreement with 
other studies (Hong et al. 2008; Vo et al. 2010; Harries et al. 2011; Marttila et al. 2013). 
Several genes involved in antigen processing and presentation were upregulated in the 
elderly. These genes include cathepsin H (CTSH), cathepsin L1 (CTSL1), major 
histocompatibility complex, class II, DR alpha (HLA-DRA) and major histocompatibility 
complex, class II, DP beta 1 (HLA-DPB1). One of the major characteristics associated with 
advanced age is chronic low-grade inflammation (inflamm-ageing) (Franceschi et al. 
2000a), which arises from continual antigenic stress. Inflammatory genes, such as 
interleukin-6 signal transducer (IL6ST) and CD40 ligand (CD40LG) were downregulated in 
LLI as reported previously (Abdul Rahman et al. 2013). In contrast to a previous study 
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(Vo et al. 2010), tumor necrosis factor superfamily member 1A (TNFRSF1A) was 
downregulated in LLI. Additionally, anti-inflammatory cytokines like interleukin-10 (IL10) 
and interleukin-18 (IL18) were upregulated. Overall, the changes observed in LLI on the 
transcriptome level indicate that immune-related processes are not altered in single 
direction over time, but appear to be continuously remodeled as proposed by 
Franceschi. This remodeling starts at birth and ensures an on-going adaptation of the 
immune system to the dynamically changing requirements of different ages.  
According to the network theory, the ageing process is indirectly controlled by a variety 
of defense and anti-stress responses (Franceschi et al. 2000a). There are various 
stressors including physical (heat, UV and gamma radiation), chemical (reducing sugars, 
products of metabolism such as oxygen-free radicals) and biological (viruses, bacteria) 
agents. In the present study, several differentially expressed genes were observed to be 
associated with the GO terms such as defense response to virus and bacteria 
(GO:0051607, GO:0042742), cellular response to stress (GO:0033554) and response to 
other organisms (GO:0051707). In this context, some heat shock proteins such as heat 
shock 70 kDA protein 8 (HSPA8), heat shock 70 kDA protein 9 (HSPA9) and heat shock 90 
kDa protein 1, and beta (HSP90AB1) were found to be downregulated in LLI. Heat shock 
70 kDA protein 7 (HSPA7) and the genes encoding the members of the peroxiredoxin 
family of antioxidant enzymes, PRDX1 and PRDX5 were upregulated in the elderly. These 
findings are supported by previous studies demonstrating that overexpression of PRDX5 
in Drosophila increases resistance to oxidative stress and extends their lifespan by up to 
30% under normal conditions (Radyuk et al. 2009), and PRDX1 has been reported to play 
an important role in defense against oxidants in ageing mice (Neumann et al. 2003).      
One of the prominent events associated with age is thymic involution, the progressive 
shrinking of the thymus (Lynch et al. 2009). As a consequence, production of naïve T-
cells declines with age, while the proportion of memory T-cells increases (Lynch et al. 
2009). It has been observed that older individuals are more susceptible to infectious 
diseases than younger population (Bender 2003). For instance, influenza is a common 
Discussion                                             
76 
 
infection in the elderly and is associated with increased morbidity (Gavazzi and Krause 
2002). Vaccination can prevent infection and protect the vulnerable elderly population 
from such infectious diseases. However, the age-associated changes in the immune 
system as mentioned above affect the efficacy of vaccines in the elderly (Aspinall et al. 
2007). Most vaccines are less efficient in aged individuals because of changes in the 
immune system (Weinberger and Grubeck-Loebenstein 2012). Although direct 
functional inferences cannot be drawn from the results of the current study, the 
observed alterations in genes related to immune processes might play a role in the 
reduced efficacy of vaccines.  
 
4.9 Depletion of cell and tissue regeneration in long-lived individuals 
With age, there is a gradual decline in the homeostatic and regenerative capacity of all 
tissues and organs (Kirkwood 2005; Liu and Rando 2011). The age-related changes in 
cellular components caused by the accumulation of random damage in somatic cells, 
oxidative damage and other mechanisms lead to physiological changes and to impaired 
responses of tissues to injury (Conboy and Rando 2005). The reduced responses to 
injury are exemplified by poor wound healing of skin in older individuals (Gosain and 
DiPietro 2004). The age-associated decreases in tissue regenerative responses can be 
attributed to a decreased number of adult stem cells and decline in their ability to 
engage in tissue repair (Pekovic and Hutchison 2008).  
Repair mechanisms play a crucial role in cell regeneration and the maintenance of 
genomic stability, and are consequently considered central to longevity (Kenyon and 
Gerson 2007). Although several repair-related processes such as DNA repair 
(GO:0006281), mismatch repair (GO:0006298), nucleotide-excision repair (GO:0006289) 
and base-excision repair (GO:0006284) are defined GO terms, they were not 
significantly represented by the differentially expressed genes.  Therefore, the results of 
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the present study do not allow drawing conclusions about the involvement of repair in 
longevity.  
In contrast, many more downregulated genes than expected by chance were associated 
with several cellular processes such as cell cycle, organelle organization, cellular 
localization, stem cell maintenance, regulation of cellular component organization and 
maintenance of cell polarity. On the other hand, far fewer upregulated genes than 
expected by chance were associated with processes such as regulation of 
developmental process, tissue and organ morphogenesis, cell differentiation and 
cellular component movement. Together, these findings imply that these processes are 
significantly depleted in LLI, further supporting the hypothesis of an age-associated 
impaired regenerative capacity.  
  
4.10 Longevity-associated molecular patterns are driven by genetic and 
environmental factors  
Twin studies have suggested that the longevity phenotype is influenced by both genetic 
and environmental factors. In this study, a similar observation was made on the 
transcriptome level, where the variation in gene expression was found to be influenced 
by both of these factors. Of the differentially expressed genes, 19.74% were under the 
influence of cis-variants, while the remaining genes were potentially controlled by trans-
variants and/or non-genetic components, like environmental factors. The heritability 
analysis using a classical twin design further confirmed that the expression variation in 
approximately 20% of the genes could be explained by genetics, while for 80% of the 
genes the expression variation is explained by environmental influences.  
The functional categorization of the differentially expressed genes led to the 
identification of three broad categories: metabolic processes, immune and defense 
response and cell and tissue regeneration. The investigation of the effects of cis-
Discussion                                             
78 
 
regulation and G×A interactions on gene expression provided an opportunity to 
determine the contribution of these factors to the biological processes associated with 
longevity. Around 20% of the genes involved in each of the processes were regulated by 
cis-interactions. Consequently, the majority of genes and processes may be driven by 
trans-interactions and/or environmental factors. Figure 4-1 depicts the biological 
processes significantly represented and the contribution of genetic factors to each of 
them. Furthermore, the heritability analysis illustrated that for most genes under 
genetic control, only part of their variation at the transcript level is explained by 
genetics. This emphasizes that genetic contribution to longevity might still be 
substantially influenced by non-genetic factors, thus increasing the heterogeneity in the 
results and lowering the power of such studies. At the same time, this observation 
encourages further studies to focus on functional aspects of the molecular phenotype of 
longevity.          
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Figure 4-1 The contribution of genetic and non-genetic factors to the biological processes 
associated with the differentially expressed genes. Circles illustrate different biological 
processes, color coded by process category. The number of genes involved in each process is 
reflected by the area of the circle.   
 
4.11 A large number of variants contribute to the same longevity-
associated biological processes 
In the present study, the eQTL analysis identified 8,757 significant cis-eQTLs associated 
with 1,200 genes, indicating that genes were regulated by multiple variants; on average, 
each gene was regulated by seven variants (in the German sample). These observations 
suggest that a large number of heterogeneous genetic components influence longevity-
associated biological processes, which finally may lead to the same phenotype, longevity 
(Figure 4-2). Consequently, the same molecular phenotype (e.g., the depletion of 
metabolic processes) can result from multiple different genetic variants. The scenario 
created by this hypothesis could explain how different population-specific architectures 
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lead to a shared longevity phenotype without the same underlying genetic factors. 
These findings, therefore, partially explain why the replication of longevity associations 
is a challenging task.       
   
 
Figure 4-2 Hierarchical organization of eQTL effects on longevity  
 
4.12 Transcriptome patterns associated with normal ageing vs. 
longevity 
In the present study, thousands of genes were differentially expressed between the two 
age groups, long-lived and young individuals. The changes observed in the mRNA 
expression levels may be due to the normal ageing processes or may reflect the healthy 
ageing as the individuals investigated were exceptionally old (91–104 years). However, 
the cross-sectional approach employed here does not distinguish between changes that 
are the result of normal ageing and those that contribute to healthy ageing and 
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predispose individuals to the longevity phenotype. A longitudinal study, in which 
individuals from a given birth cohort are followed over time, may help discriminate 
between these changes. Additionally, since the controls used in cross-sectional designs 
originate from birth cohorts separate from those of the LLI, cohort-specific differences 
might confound the observations. However, using a longitudinal approach, individuals 
from a specific birth cohort are followed over time, controlling for cohort-specific 
differences. The findings from longitudinal studies however are very specific to the 
investigated cohort. While the cross-sectional design has a limited ability to 
demonstrate causality, results obtained from longitudinal studies are not broadly 
applicable across birth cohorts, and therefore, caution is necessary when making 
inferences regarding the causal effects on longevity. 
 
4.13 Conclusion and outlook 
In conclusion, RNA-sequencing-based genome-wide expression and eQTL analysis 
documented the depletion of metabolic processes, which is potentially causative for 
longevity in humans. Moreover, only a small proportion of this depletion of metabolism 
was explained by genetic contributions, further supporting the influence of non-genetic 
factors like environment. In addition, the remodeling of immune and defense response 
and depletion of cell and tissue regeneration were observed in LLI. Finally, this study 
provides a model to explain why longevity associations are difficult to replicate in 
alternative populations: in a hierarchical manner, a large number of different genetic 
variants can contribute to the expression of several genes, which in turn influences only 
a small set of biological processes. Consequently, many different genetic variants can 
lead to the same molecular outcome. 
Although the age-associated genes were controlled by both genetic and non-genetic 
factors, the individual contribution of these factors remains unclear and requires further 
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investigation. It is evident from the literature that gene expression is regulated by 
epigenetic processes (Gibney and Nolan 2010), microRNA (miRNA) (Cannell et al. 2008) 
as well as natural genetic variation (Williams et al. 2007). Among the epigenetic 
modifications, DNA methylation is the best known and has a crucial role in the 
regulation of gene expression (Aguilera et al. 2010). Additionally, there is a growing 
body of evidence highlighting the role of DNA methylation and miRNAs in healthy ageing 
and longevity (ElSharawy et al. 2012; Heyn et al. 2012). Further investigation of the DNA 
methylation status and miRNAs in the samples used here could provide an even more 
detailed understanding of the molecular patterns associated with longevity.       
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5 Summary (English) 
The demographic change as a result of continuously increasing life expectancy will be a 
major challenge for society, economy and health care. Besides other approaches 
addressing these challenges, understanding the molecular mechanisms of human 
longevity can contribute to extend the health span of the elderly and reduce the risk of 
disabilities and diseases. As human longevity is influenced by genetic and environmental 
factors, this study aims to monitor the functional consequences of both, employing an 
expression quantitative trait loci (eQTL) approach based on RNA-sequencing and 
genotype data. Blood samples from 244 individuals (age range, 20–104 years; 148 
unrelated individuals and 96 twins) were analyzed in order to 1) investigate the 
transcriptome patterns associated with human longevity; 2) assess the influence of 
natural genetic variation on the identified transcriptome patterns; 3) investigate the 
heritability of transcriptional activity. Approximately 20% of the 6,078 genes that were 
differentially expressed between long-lived individuals (LLI) and young controls were 
influenced by cis-variants, and 50% of those cis-regulated genes exhibited genotype-age 
interaction effects. Consequently, gene regulation is influenced by both genetic and 
non-genetic factors. This observation was also supported by the subsequent heritability 
analysis carried out in twins. Interestingly, functional categorization of the differentially 
expressed genes revealed that metabolism-associated processes were significantly 
depleted in LLI, supporting the hypothesis that reduced metabolic rates contribute to 
human longevity. The eQTL approach employed here showed that the depletion of 
metabolic processes is potentially causative for longevity, yet the genetic contribution of 
about 20% indicates that non-genetic factors play a key role. Furthermore, the findings 
illustrate that different genetic variations can lead to the same molecular outcome, 
explaining the difficulties in validating genetic association findings in longevity research. 
Taken together, the presented results can contribute to the understanding of longevity, 
which is a starting point when addressing the challenging tasks resulting from the 
massive demographic changes in our society. 
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6 Summary (German) 
Die kontinuierlich steigende Lebenserwartung führt zu einem demographischen 
Wandel, der Gesellschaft, Wirtschaft und Gesundheitssystem vor enorme 
Herausforderungen stellt. Um langfristig gesundes Altern zu ermöglichen, sowie um 
Krankheitsrisiken in älteren Bevölkerungsgruppen zu verringern, ist ein Verständnis der 
molekularen Mechanismen der Langlebigkeit dringend erforderlich. Da Langlebigkeit bei 
Menschen sowohl durch genetische Faktoren als auch durch Umweltfaktoren beeinflußt 
wird, war es Ziel der vorliegenden Studie, die funktionellen Konsequenzen beider 
Einflüsse abzubilden. Hierzu wurde ein sogenannter eQTL-Ansatz gewählt, der 
Sequenzierungsbasierte Trankriptomdaten mit Genotypisierungdaten verbindet. 
Blutproben von 244 Individuen (Altersspanne, 20–104 Jahre; 148 unverwandte 
Individuen und 96 Zwillinge) wurden eingesetzt um 1) die altersassoziierten 
Transkriptommuster zu untersuchen; 2) um den Einfluß genetischer Variation auf die 
identifizierten Transkriptommuster zu ermitteln und 3) um die Vererbbarkeit von 
Transkriptommustern darzustellen. Etwa 20% der 6,078 altersabhängig regulierten Gene 
unterlagen einer genetischen Kontrolle durch cis-Varianten, von denen wiederum etwa 
50% einen Interaktionseffekt zwischen Alter und Genotyp zeigten. Daraus konnte 
abgeleitet werden, daß regulierte Gene sowohl durch genetische als auch durch nicht 
genetische Faktoren beeinflußt werden. Diese Beobachtung wurde zusätzlich durch eine 
nachfolgende Heritabilitätsanalyse bestätigt. Das zentrale Ergebnis der vorliegenden 
Arbeit ergab sich durch die funktionelle Kategorisierung der regulierten Gene: Mit 
Metabolismus verknüpfte biologische Prozesse zeigten in langlebigen Individuen eine 
signifikante Depletion. Dies ist im Einklang mit der Vermutung, daß reduzierte 
metabolische Raten zur Langlebigkeit beitragen. Der hier gewählte eQTL-Ansatz 
ermöglicht zwar, eine potentielle Kausalität dieser Depletion für Langlebigkeit zu 
folgern, jedoch deutet der genetische Beitrag von 20% auf einen überwiegenden Anteil 
nicht-genetischer Einflüsse hin. Der Befund, daß verschiedene genetische Varianten zum 
selben molekularen Ergebnis führen können, erklärt darüber hinaus die anhaltenden 
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Probleme, genetische Assoziationen in der Altersforschung zu validieren. Abschließend 
können die hier vorgelegten Ergebnisse zum Verständniss der Langlebigkeit beitragen, 
und stellen somit eine wichtige Voraussetzung dar, um sich den Herausforderungen in 
Folge des massiven demographischen Wandels zu stellen. 
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8 Supplementary material 
 
8.1 Genes with significant gender effect 
 
Table 8-1 Genes that exhibited significant gender effect 
Gene symbol Gene loci Gender 
CoefficientƗ 
p-value Adjusted p-
value 
HDHD1 chrX:6966960-7066231 0.709 5.77E-25 1.75E-21 
RPS4X chrX:71492452-71497141 0.545 2.12E-13 4.3E-10 
TXLNG chrX:16804554-16862642 0.487 2.03E-12 3.09E-09 
EIF1AX chrX:20142635-20159966 0.506 1.87E-11 2.27E-08 
ZFX chrX:24167761-24234372 0.498 3.09E-11 3.13E-08 
EIF2S3 chrX:24073064-24096927 0.454 2.36E-10 1.95E-07 
ZRSR2 chrX:15808573-15841382 0.461 2.78E-10 1.95E-07 
CA5B chrX:15756411-15805748 0.484 2.88E-10 1.95E-07 
KDM6A chrX:44732422-44971845 0.476 5.81E-10 3.54E-07 
KDM5C chrX:53220502-53254604 0.432 4.17E-08 2.3E-05 
VSIG1 chrX:107288199-107322414 0.391 4.55E-08 2.3E-05 
SEPT6 chrX:118749687-118827333 0.408 1.10E-07 5.16E-05 
PLD6 chr17:17104308-17109646 0.413 1.98E-07 8.6E-05 
AZU1 chr19:827830-832017 -0.410 2.44E-07 9.89E-05 
OXNAD1 chr3:16306666-16347594 0.341 3.23E-07 0.000123 
LTB chr6:31548335-31550202 0.385 3.67E-07 0.000131 
SYT11 chr1:155829259-155854990 -0.386 6.63E-07 0.000224 
CDK16 chrX:47077527-47089394 0.362 1.01E-06 0.000309 
LOC439949 chr10:6622386-6627323 0.382 1.02E-06 0.000309 
OPLAH chr8:145106166-145115584 0.380 1.32E-06 0.000382 
GUSB chr7:65425672-65447301 -0.385 1.44E-06 0.000398 
SCML4 chr6:108023363-108145521 0.380 1.53E-06 0.000405 
TBX21 chr17:45810609-45823485 -0.384 1.65E-06 0.000417 
PTGDS chr9:139871955-139876194 -0.353 2.53E-06 0.000616 
RNF157 chr17:74138533-74236390 0.371 3.32E-06 0.000777 
OSBPL5 chr11:3108345-3186582 -0.349 3.90E-06 0.000878 
ZSCAN18 chr19:58595208-58629793 0.335 4.38E-06 0.000952 
LILRB1 chr19:55128628-55149004 -0.380 4.64E-06 0.000973 
PIK3R3 chr1:46505811-46598708 -0.347 4.88E-06 0.000989 
PDGFRB chr5:149493401-149535422 -0.313 6.29E-06 0.001233 
DEFA4 chr8:6793344-6795786 -0.367 6.91E-06 0.001311 
REEP4 chr8:21995532-21999448 -0.335 7.11E-06 0.001311 
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Gene symbol Gene loci Gender 
CoefficientƗ 
p-value Adjusted p-
value 
LGR6 chr1:202163117-202288889 -0.324 7.79E-06 0.001389 
PTPN18 chr2:131113579-131132982 -0.356 8.09E-06 0.001389 
CD40LG chrX:135730335-135742549 0.314 8.27E-06 0.001389 
HAPLN3 chr15:89420518-89438770 0.367 8.45E-06 0.001389 
MTERFD2 chr2:242026508-242041747 0.350 8.76E-06 0.001401 
TMEM63A chr1:226033232-226070420 0.284 9.10E-06 0.001419 
SUSD1 chr9:114803060-114937556 -0.347 1.07E-05 0.001628 
GPR56 chr16:57653909-57698944 -0.361 1.23E-05 0.001827 
C13orf15 chr13:42031541-42045013 0.332 1.88E-05 0.002723 
TTC38 chr22:46663860-46689905 -0.316 2.52E-05 0.003513 
ABI3 chr17:47287588-47300587 -0.315 2.54E-05 0.003513 
HAVCR2 chr5:156512842-156536248 -0.326 2.81E-05 0.003804 
ZFP28 chr19:57050316-57068170 0.306 2.98E-05 0.003938 
PIK3IP1 chr22:31677578-31688520 0.261 3.15E-05 0.00408 
CD63 chr12:56119229-56122910 -0.310 3.44E-05 0.004285 
CUX1 chr7:101459183-101927250 -0.347 3.45E-05 0.004285 
LRRC16B chr14:24521205-24538937 -0.316 3.57E-05 0.004328 
FANCI chr15:89787193-89860362 -0.318 3.63E-05 0.004328 
CMKLR1 chr12:108681820-108733094 -0.337 3.77E-05 0.004404 
MYO1G chr7:45002259-45018704 -0.328 4.67E-05 0.005295 
GAL3ST4 chr7:99756864-99766373 0.323 4.70E-05 0.005295 
GOLM1 chr9:88641057-88715116 -0.323 4.92E-05 0.005444 
WDR19 chr4:39184023-39287430 0.317 5.29E-05 0.00574 
CCR7 chr17:38710021-38721736 0.256 5.80E-05 0.006189 
ADPRH chr3:119298522-119308792 -0.325 6.20E-05 0.006426 
LINC00246B chrX:72161567-72163589 0.298 6.23E-05 0.006426 
SLC22A23 chr6:3269206-3456793 0.305 7.06E-05 0.007123 
EPHX2 chr8:27348518-27402439 0.289 7.18E-05 0.007123 
ELANE chr19:852290-856246 -0.333 7.26E-05 0.007123 
VMAC chr19:5904851-5910263 0.304 7.55E-05 0.007292 
ICOS chr2:204801470-204826298 0.303 8.43E-05 0.008007 
LRRN3 chr7:110731061-110765509 0.186 8.71E-05 0.00815 
TMEM204 chr16:1578741-1605581 0.311 8.87E-05 0.008155 
CTSG chr14:25042723-25045466 -0.322 8.98E-05 0.008155 
C2orf89 chr2:85048795-85108252 0.258 0.000109 0.009763 
RRBP1 chr20:17594322-17662928 -0.326 0.000117 0.010315 
ASCL2 chr11:2289727-2292182 -0.279 0.000121 0.010487 
FBXL16 chr16:742499-755825 0.325 0.000124 0.010645 
GPR183 chr13:99946788-99959749 0.312 0.000126 0.010668 
CAMK4 chr5:110559946-110820748 0.227 0.000133 0.01104 
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Gene symbol Gene loci Gender 
CoefficientƗ 
p-value Adjusted p-
value 
CD274 chr9:5450502-5470567 0.304 0.000142 0.011632 
NKG7 chr19:51874873-51875960 -0.299 0.000153 0.012391 
ZNF101 chr19:19779662-19791138 0.292 0.000166 0.013316 
PLXNB1 chr3:48445260-48471460 -0.299 0.000169 0.013341 
TIMD4 chr5:156346292-156390266 0.306 0.000175 0.013648 
ZNF862 chr7:149535508-149564568 0.312 0.000186 0.014349 
LOC100130231 chr8:126934766-126963441 0.291 0.000206 0.015688 
SFTPD chr10:81697495-81708861 -0.295 0.00021 0.015737 
N6AMT1 chr21:30244512-30257693 0.275 0.000225 0.016658 
ALDH3B1 chr11:67776047-67796743 -0.282 0.000231 0.016902 
FAM179A chr2:29204163-29275096 -0.273 0.000237 0.017188 
BACH2 chr6:90636246-91006627 0.213 0.000274 0.019574 
KPNA2 chr17:66031847-66042970 -0.280 0.000295 0.020695 
PODN chr1:53527723-53551174 -0.278 0.000299 0.020695 
NT5E chr6:86159301-86205509 0.218 0.000299 0.020695 
CD244 chr1:160799949-160832692 -0.268 0.000309 0.021101 
SLC27A3 chr1:153747767-153752633 -0.241 0.000327 0.021984 
CASP4 chr11:104813593-104839325 0.271 0.000333 0.021984 
RPS6KA4 chr11:64126624-64139687 -0.284 0.000335 0.021984 
PLOD3 chr7:100849257-100861011 -0.297 0.000336 0.021984 
ZNF607 chr19:38187263-38210691 0.280 0.000356 0.022842 
STXBP1 chr9:130374485-130454995 0.292 0.000357 0.022842 
SERINC5 chr5:79407049-79551898 0.230 0.000365 0.023153 
LOC100505696 chr3:15295690-15306005 0.287 0.000373 0.02327 
RCAN3 chr1:24828840-24863510 0.197 0.000375 0.02327 
CHN1 chr2:175664041-175870107 0.280 0.000384 0.023586 
ANXA2 chr15:60639349-60690185 -0.261 0.000419 0.025439 
FAM102A chr9:130702860-130742812 0.208 0.000422 0.025439 
FLJ39653 chr4:16228285-16259810 0.295 0.000432 0.0256 
GLB1L chr2:220101502-220110131 -0.273 0.000434 0.0256 
AK5 chr1:77747661-78025654 0.267 0.000442 0.025861 
MLC1 chr22:50497819-50524358 -0.281 0.000447 0.02588 
N4BP3 chr5:177540555-177553107 0.218 0.000451 0.02588 
FUCA2 chr6:143815948-143833020 -0.259 0.000456 0.025901 
FIG4 chr6:110012423-110146634 -0.285 0.000466 0.026224 
AQP3 chr9:33441151-33447631 0.216 0.000486 0.026962 
MAST4 chr5:65892175-66465423 0.272 0.000488 0.026962 
PDE4A chr19:10527448-10580307 -0.261 0.0005 0.027192 
KIAA0930 chr22:45588122-45636650 -0.279 0.000501 0.027192 
MRPS25 chr3:15090018-15106816 0.286 0.000516 0.027791 
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Gene symbol Gene loci Gender 
CoefficientƗ 
p-value Adjusted p-
value 
RCC2 chr1:17733250-17766250 -0.276 0.000526 0.02784 
SH3TC1 chr4:8201059-8242830 -0.268 0.000526 0.02784 
GCET2 chr3:111839687-111852152 0.276 0.000573 0.030054 
TBC1D4 chr13:75858808-76056250 0.242 0.000594 0.03086 
STMN3 chr20:62271060-62284780 0.286 0.000635 0.032727 
CTIF chr18:46065426-46389586 -0.284 0.000641 0.032743 
TCN2 chr22:31003069-31023047 -0.255 0.000646 0.032765 
PRTN3 chr19:840984-848175 -0.280 0.000666 0.033487 
IGSF9B chr11:133785184-133826880 0.268 0.000677 0.033741 
INADL chr1:62208148-62629591 0.228 0.000694 0.034317 
SOCS1 chr16:11348273-11350039 0.270 0.000701 0.034382 
CA5BP1 chrX:15693038-15721474 0.269 0.000715 0.034773 
C1orf21 chr1:184356149-184598155 -0.259 0.000738 0.035601 
KIAA0748 chr12:55343864-55378456 0.239 0.000752 0.036036 
RASSF4 chr10:45455218-45490172 -0.248 0.000783 0.037194 
KIR2DL3 chr19:55249973-55264504 -0.273 0.000796 0.037395 
OAF chr11:120081746-120100650 -0.271 0.000801 0.037395 
ZNF548 chr19:57901217-57913919 0.242 0.000805 0.037395 
GBP2 chr1:89573309-89591799 0.273 0.000823 0.037905 
SLAMF7 chr1:160709076-160724601 -0.278 0.000834 0.037905 
AXIN2 chr17:63524682-63557740 0.220 0.000835 0.037905 
ITPRIPL1 chr2:96991061-96994091 -0.265 0.00089 0.040091 
C1orf216 chr1:36179476-36184790 -0.238 0.000899 0.040095 
FXYD6 chr11:117707690-117748201 -0.265 0.000903 0.040095 
PIM2 chrX:48770458-48776413 0.270 0.000913 0.040101 
ZNF385A chr12:54762919-54785083 -0.272 0.000916 0.040101 
CD96 chr3:111260925-111371206 0.232 0.000938 0.040745 
GZMB chr14:25100160-25103432 -0.256 0.000951 0.040765 
OTOF chr2:26680070-26781566 -0.283 0.000952 0.040765 
BIRC3 chr11:102188180-102210135 0.260 0.000967 0.041132 
PTPN9 chr15:75759461-75871625 -0.266 0.000982 0.041463 
CD33 chr19:51728334-51743274 -0.259 0.001 0.041948 
PTPRK chr6:128289923-128841870 0.251 0.001009 0.041948 
PLEKHB1 chr11:73357222-73373864 0.271 0.001014 0.041948 
MPRIP chr17:16946073-17095962 0.225 0.001024 0.041948 
DHRS12 chr13:52342130-52378293 0.243 0.001029 0.041948 
NOG chr17:54671059-54672951 0.187 0.001041 0.041948 
KANK1 chr9:504702-746103 0.268 0.001044 0.041948 
FAM69A chr1:93298285-93427079 0.250 0.001059 0.041948 
CARD9 chr9:139258407-139268133 -0.259 0.001065 0.041948 
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Gene symbol Gene loci Gender 
CoefficientƗ 
p-value Adjusted p-
value 
AMIGO1 chr1:110049445-110052336 0.218 0.001073 0.041948 
FAM113B chr12:47610051-47630443 0.258 0.001074 0.041948 
CLDND2 chr19:51870351-51872257 -0.248 0.001076 0.041948 
PAK6 chr15:40509628-40569688 -0.264 0.001112 0.043059 
BCL2 chr18:60790578-60986613 0.227 0.001125 0.043316 
DGKE chr17:54911459-54946036 0.252 0.001144 0.043587 
FCGR1B chr1:120926127-120935944 0.224 0.001149 0.043587 
ZIK1 chr19:58095627-58103758 0.241 0.001159 0.043587 
SLC4A2 chr7:150755298-150773614 -0.249 0.001161 0.043587 
ANXA4 chr2:69969126-70053596 -0.272 0.001198 0.043934 
KCTD11 chr17:7255207-7258262 -0.246 0.001198 0.043934 
APLP2 chr11:129939715-130014706 -0.264 0.001203 0.043934 
CDR2 chr16:22357256-22385938 0.216 0.001209 0.043934 
FAM134B chr5:16473146-16617167 0.220 0.001214 0.043934 
C2orf18 chr2:26987141-27004099 -0.256 0.001214 0.043934 
PLOD1 chr1:11994723-12035599 -0.265 0.001241 0.044663 
ZNF470 chr19:57078889-57094262 0.230 0.001271 0.04547 
PRSS23 chr11:86511490-86522273 -0.263 0.001287 0.045765 
EMP3 chr19:48828628-48833810 -0.263 0.001301 0.046005 
RAB13 chr1:153954127-153958806 -0.232 0.001319 0.04636 
DPP3 chr11:66247483-66277130 -0.260 0.00135 0.046958 
IL18BP chr11:71709957-71713965 -0.257 0.001351 0.046958 
ANKRD40 chr17:48770550-48785270 -0.240 0.001369 0.047323 
SLC1A4 chr2:65215578-65251000 -0.256 0.001382 0.047494 
NELL2 chr12:44902057-45307711 0.178 0.001443 0.04926 
IL6ST chr5:55230924-55290821 0.231 0.00145 0.04926 
ƗPositive gender coefficient means upregulated in females and negative coefficient 
means downregulated in females. 
 
8.2 All the genes that highly correlated with blood cell populations 
 
Table 8-2 The genes that were highly correlated with blood cell populations  
Gene symbol Loci Cell type p-value* Fold change 
TCF7 chr5:133450401-133483920 T 2.43E-13 -2.39856663 
LEF1 chr4:108968700-109090112 T 5.59E-13 -2.57074344 
BCL11B chr14:99635624-99737822 T 2.78E-12 -1.76062008 
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Gene symbol Loci Cell type p-value* Fold change 
CR2 chr1:207627644-207663240 B 3.08E-12 -3.76381326 
ITGA6 chr2:173292313-173371181 T 5.14E-12 -2.37591824 
CD28 chr2:204571197-204603636 T 3.14E-11 -1.96158576 
KYNU chr2:143635194-143799885 B 3.60E-11 1.785216714 
CDKN2A chr9:21967750-21994490 B 5.09E-11 2.793669958 
LEPROTL1 chr8:29952921-29995222 T 1.59E-10 -1.56190513 
DPP4 chr2:162848754-162931052 T 2.75E-10 -1.65053464 
IL7R chr5:35856990-35876923 T 2.12E-09 -4.56587447 
ITK chr5:156607906-156682109 T 3.67E-09 -2.23731557 
RNASE2 chr14:21423629-21424594 GRANS 5.73E-09 3.037626956 
AAK1 chr2:69685126-69870977 T 6.48E-09 -1.3342541 
SUN2 chr22:39130718-39152024 B 9.44E-09 -1.35764176 
ATG4A chrX:107334898-107397901 B 2.48E-08 1.337542386 
PDK1 chr2:173420778-173463862 GRANS 3.40E-08 -1.55828365 
PMEPA1 chr20:56223447-56286592 B 3.94E-08 -1.82848518 
RAB30 chr11:82692477-82782884 B 6.24E-08 -1.71492263 
TXK chr4:48068409-48136273 T 7.47E-08 -1.76161535 
PLXDC1 chr17:37219555-37307902 T 8.96E-08 -1.68919167 
RHOH chr4:40198526-40246281 B 1.09E-07 -1.41751388 
OSBPL10 chr3:31702316-32023342 B 1.37E-07 -1.86839612 
STRBP chr9:125883907-126030855 B 1.40E-07 -1.52026108 
CD3G chr11:118215058-118224497 T 1.45E-07 -2.17305748 
AKTIP chr16:53525191-53537170 T 1.67E-07 -1.30988158 
TNFRSF10A chr8:23048969-23082680 GRANS 1.81E-07 -1.61562624 
KRIT1 chr7:91828282-91875414 GRANS 2.21E-07 -1.70020532 
INPP4B chr4:142949181-143767604 T 2.65E-07 -1.53426759 
DENND4B chr1:153901976-153919154 B 2.88E-07 -1.27486711 
SLFN5 chr17:33570085-33594761 T 3.58E-07 -2.35187419 
INPP4A chr2:99061320-99207496 T 5.44E-07 -1.60455817 
AFF3 chr2:100163715-100759037 B 5.74E-07 -2.00251351 
TNFRSF25 chr1:6521213-6526255 T 7.17E-07 -1.41812169 
BANK1 chr4:102711763-102995969 B 1.01E-06 -1.68607565 
CSF2RB chr22:37309674-37336479 GRANS 1.38E-06 -2.25989869 
BCL7A chr12:122459860-122499950 B 1.91E-06 -1.57385447 
CHERP chr19:16628699-16653263 B 1.93E-06 -1.30829367 
STAT6 chr12:57489186-57505196 B 2.02E-06 -1.26965447 
SEL1L3 chr4:25749048-25864610 B 2.02E-06 -1.52646456 
S100P chr4:6695565-6698897 GRANS 2.49E-06 2.268856333 
SOAT1 chr1:179262848-179327814 GRANS 2.68E-06 -1.36178056 
TCF4 chr18:52889561-53303188 B 2.85E-06 -1.72305208 
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Gene symbol Loci Cell type p-value* Fold change 
FCRL1 chr1:157764193-157789940 B 3.14E-06 -2.66749882 
ANXA1 chr9:75766780-75785307 T 3.21E-06 1.703869068 
ARHGAP10 chr4:148653452-148993927 B 3.69E-06 1.446942521 
PCSK5 chr9:78505559-78977255 T 4.10E-06 -1.59743834 
DENND5B chr12:31535156-31743952 B 4.37E-06 -1.92996297 
MLLT3 chr9:20344967-20622514 T 4.49E-06 -1.27728012 
WIPF1 chr2:175424301-175547627 B 4.89E-06 -1.55767299 
FYB chr5:39105353-39270759 T 4.93E-06 -2.13059611 
CXCR2 chr2:218990012-219001976 GRANS 4.93E-06 -1.74039383 
C11orf24 chr11:68028802-68039469 B 5.20E-06 1.304781394 
CHD7 chr8:61591323-61780586 B 5.25E-06 -1.60233256 
APBA2 chr15:29213839-29410516 T 6.10E-06 -1.40568735 
AIM2 chr1:159032274-159046647 B 8.57E-06 1.664838234 
RALGPS2 chr1:178694299-178889237 B 8.57E-06 -1.83463858 
CCND2 chr12:4382901-4414522 T 9.63E-06 -1.26485679 
SEC14L1 chr17:75084724-75213181 GRANS 9.99E-06 -1.65019851 
HUWE1 chrX:53559062-53713673 B 1.05E-05 -1.31201267 
RALGAPB chr20:37101485-37207504 B 1.09E-05 -1.51038157 
XYLT1 chr16:17196180-17564738 B 1.34E-05 -1.45000951 
RCSD1 chr1:167599473-167675486 B 1.46E-05 -1.54096829 
CXCR5 chr11:118754474-118766980 B 1.51E-05 -1.57968065 
PSEN2 chr1:227058272-227083804 B 1.58E-05 1.324624056 
MAL chr2:95691478-95719735 T 1.62E-05 -1.48756006 
FBLN5 chr14:92335754-92414046 T 1.96E-05 -1.5188418 
LGALS3 chr14:55595934-55612148 GRANS 2.49E-05 1.263370708 
CECR6 chr22:17597188-17602257 GRANS 2.70E-05 1.532266751 
TMED8 chr14:77808113-77843396 B 3.36E-05 -2.4736054 
WDR11 chr10:122610686-122669038 B 3.45E-05 -1.33398908 
SNX29 chr16:12070601-12668146 B 3.55E-05 -1.55610738 
IRF8 chr16:85932773-85956211 B 3.58E-05 -1.3155995 
ATP6V1B2 chr8:20054703-20079207 GRANS 4.29E-05 -1.2955278 
SWAP70 chr11:9685627-9774507 B 5.21E-05 -1.48165763 
SNX10 chr7:26331514-26413949 B 5.26E-05 -1.80573425 
MS4A1 chr11:60223281-60238225 B 5.26E-05 -2.08502361 
LDHB chr12:21788274-21810789 GRANS 5.56E-05 -1.31628978 
HLA-DMA chr6:32916390-32920899 B 5.76E-05 1.21468926 
ZNF207 chr17:30677156-30697468 B 6.43E-05 -1.22581395 
SHFM1 chr7:96318078-96339203 T 7.07E-05 1.330616373 
KIAA0226L chr13:46916136-46961635 B 8.07E-05 -1.43925697 
LY86 chr6:6588933-6655216 B 9.37E-05 1.420867778 
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Gene symbol Loci Cell type p-value* Fold change 
IL4R chr16:27325250-27376099 B 9.37E-05 -1.4286932 
LYPLA2 chr1:24117645-24122029 GRANS 9.64E-05 1.248433939 
KLHL14 chr18:30252633-30352974 B 9.81E-05 -2.60789518 
MME chr3:154797435-154901518 GRANS 0.000102 -1.48782137 
TSPAN3 chr15:77336359-77363570 B 0.000103 -1.30257191 
VPS28 chr8:145648999-145653927 B 0.000111 1.208069301 
MXD1 chr2:70142172-70170076 GRANS 0.000112 -1.57999332 
CD6 chr11:60739112-60787848 T 0.000116 -1.1990339 
TRIO chr5:14143828-14509458 B 0.000125 -1.58201107 
FCRL2 chr1:157715522-157746922 B 0.000125 -1.83220983 
SPEG chr2:220299699-220358354 T 0.000138 -1.6892117 
KDM4B chr19:4969123-5153608 B 0.00015 -1.30929965 
RTN3 chr11:63448921-63527363 GRANS 0.000153 -1.26492486 
CDCA7L chr7:21940516-21985542 B 0.000156 -1.29572908 
MGAM chr7:141695678-141806547 GRANS 0.000156 -1.82350858 
SRGAP2 chr1:206516199-206637783 B 0.000164 1.2179099 
BRD4 chr19:15348300-15391262 B 0.000182 -1.26693715 
CD200 chr3:112051915-112081658 B 0.000183 -1.78723988 
MIR600HG chr9:125871772-125877756 B 0.000186 -1.3383663 
TMC6 chr17:76108998-76128488 T 0.000186 -1.17608314 
TRERF1 chr6:42192668-42419783 T 0.000196 -1.33627049 
GLUL chr1:182350838-182361341 GRANS 0.000207 -1.31327274 
CREB5 chr7:28338939-28865511 GRANS 0.000217 -1.44919846 
DHRS9 chr2:169921298-169952677 GRANS 0.000221 1.265155403 
TNFRSF10C chr8:22960326-22974950 GRANS 0.000256 -1.24709389 
ADAM19 chr5:156904311-157002783 B 0.00026 -1.41520947 
PRICKLE1 chr12:42852139-42983572 B 0.00027 -1.61295203 
PIM1 chr6:37137921-37143204 GRANS 0.000272 -1.15709034 
ODC1 chr2:10580507-10588453 B 0.000279 -1.24208157 
IL1R2 chr2:102608305-102644884 GRANS 0.000307 1.418261391 
DNAJC10 chr2:183580998-183643255 B 0.000343 -1.53821367 
KIAA0125 chr14:106383837-106398502 B 0.000355 -1.54837624 
MOB3B chr9:27325206-27529850 B 0.000355 -1.28591649 
MRPL49 chr11:64889654-64894841 B 0.00037 -1.10489414 
EBF1 chr5:158122922-158526788 B 0.000384 -1.61732941 
TRAT1 chr3:108541630-108573714 T 0.000393 -1.61682195 
BLNK chr10:97951454-98031333 B 0.000418 -1.3335382 
NAMPT chr7:105888731-105925638 GRANS 0.000436 -1.49973432 
ARL5B chr10:18948312-18966940 GRANS 0.000451 -2.17621957 
CAMP chr3:48264836-48266981 GRANS 0.000455 2.013874324 
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Gene symbol Loci Cell type p-value* Fold change 
HLA-DMB chr6:32902405-32908847 B 0.000462 1.167226789 
KLHL12 chr1:202860229-202896371 GRANS 0.000462 -1.10967421 
E2F5 chr8:86089618-86126753 B 0.000522 -1.5173253 
BCL6 chr3:187439164-187463513 GRANS 0.000553 -1.66406785 
CCL5 chr17:34198495-34207377 T 0.000614 1.611345773 
AQP9 chr15:58430407-58478110 GRANS 0.000628 -1.2500323 
RTKN2 chr10:63952952-64028466 T 0.000643 -1.80099565 
SP140 chr2:231090444-231177930 B 0.000654 1.24826587 
FAM129C chr19:17634109-17664648 B 0.000699 -1.61811313 
LAT chr16:28996146-29002104 T 0.000717 -1.21717842 
CITED2 chr6:139693396-139695785 GRANS 0.000816 -1.24346728 
POU2AF1 chr11:111222980-111250157 B 0.000893 -1.32788055 
FCGR2B chr1:161632904-161648444 B 0.000945 1.275381058 
RXRA chr9:137218315-137332431 GRANS 0.000945 -1.159029 
* p-value is with respect to differential expression and is corrected for multiple testing; negative 
fold change represents downregulation and positive fold change represents upregulation of the 
gene in LLI; B=B-cell, T=T-cell, GRANS=granulocyte 
 
8.3 GO terms with respect to up- and downregulated genes in the 
German sample 
 
Table 8-3 All the significantly represented biological processes with respect to the genes 
upregulated and downregulated in LLI (in the German sample). 
Biological processes enriched/depleted p-value* 
With respect to the upregulated genes 
oxidation-reduction process + 6.58584E-11 
regulation of developmental process - 7.07123E-07 
generation of precursor metabolites and energy + 3.10797E-06 
regulation of cellular process - 3.10797E-06 
small molecule metabolic process + 1.5728E-05 
embryonic morphogenesis - 1.5728E-05 
regulation of signaling - 4.08626E-05 
pattern specification process - 7.01662E-05 
regulation of metabolic process - 8.71359E-05 
organ morphogenesis - 0.000220242 
cell-cell adhesion - 0.000233777 
cell adhesion - 0.000235619 
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Biological processes enriched/depleted p-value* 
cell migration - 0.000235619 
cellular response to stress + 0.001547862 
regulation of body fluid levels - 0.001547862 
tube morphogenesis - 0.001547862 
cellular developmental process - 0.001559711 
tissue morphogenesis - 0.001559711 
antigen processing and presentation of exogenous 
antigen 
+ 0.001953199 
mitochondrial transport + 0.002082563 
coagulation - 0.003328394 
cell cycle + 0.006790666 
antigen processing and presentation of peptide antigen + 0.006790666 
system development - 0.006790666 
cell differentiation - 0.009982644 
morphogenesis of a branching structure - 0.010505961 
regionalization - 0.011770173 
glutathione derivative metabolic process + 0.011770173 
cellular component movement - 0.011770173 
response to other organism + 0.013280966 
hydrogen transport + 0.013280966 
organ development - 0.013280966 
synapse organization - 0.01793919 
single-organism catabolic process + 0.018980645 
hematopoietic or lymphoid organ development - 0.025171996 
defense response to virus + 0.025171996 
regulation of response to stimulus - 0.027368965 
signal transduction - 0.030708144 
cellular response to endogenous stimulus - 0.036340253 
response to virus + 0.039529868 
tube development - 0.04358095 
viral entry into host cell via membrane fusion with the 
plasma membrane 
+ 0.04358095 
cellular catabolic process + 0.04358095 
regulation of multicellular organismal process - 0.049479985 
With respect to the downregulated genes 
cellular macromolecule metabolic process + 1.68181E-73 
regulation of metabolic process + 7.38584E-56 
macromolecule metabolic process + 2.0363E-55 
nucleobase-containing compound metabolic process + 5.34186E-49 
cellular aromatic compound metabolic process + 7.022E-44 
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Biological processes enriched/depleted p-value* 
heterocycle metabolic process + 1.30312E-43 
organic cyclic compound metabolic process + 8.25218E-38 
cellular nitrogen compound metabolic process + 2.4924E-37 
regulation of cellular process + 5.83663E-33 
cellular biosynthetic process + 1.58186E-27 
organic substance biosynthetic process + 2.62531E-26 
organelle organization + 4.74181E-19 
negative regulation of biological process + 2.72502E-09 
protein metabolic process + 1.6398E-08 
positive regulation of biological process + 5.03564E-08 
RNA transport + 7.07176E-08 
cell-cell signaling - 1.14189E-06 
modification of morphology or physiology of other 
organism involved in symbiotic interaction 
+ 1.99594E-06 
cell communication - 3.32407E-06 
modification of morphology or physiology of other 
organism 
+ 8.34453E-06 
immune response-activating signal transduction + 1.71139E-05 
interaction with host + 2.69314E-05 
embryo development + 3.83194E-05 
intracellular transport + 4.71315E-05 
cellular response to endogenous stimulus + 5.03087E-05 
phosphorus metabolic process + 7.199E-05 
cell cycle + 0.000207797 
macromolecule methylation + 0.000342191 
regulation of response to stimulus + 0.000355204 
protein transport + 0.000380449 
ion transport - 0.000380449 
system process - 0.000423557 
single-organism catabolic process - 0.000455124 
organic acid metabolic process - 0.000455124 
regulation of signaling + 0.000515664 
cell cycle process + 0.000547866 
cellular localization + 0.00060626 
cellular response to stress + 0.000641649 
cellular response to chemical stimulus + 0.000681059 
oxidation-reduction process - 0.000832884 
Golgi vesicle transport + 0.000958635 
regulation of cellular component organization + 0.001028958 
gene silencing + 0.001212995 
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Biological processes enriched/depleted p-value* 
viral process + 0.001214434 
symbiosis, encompassing mutualism through parasitism + 0.001214434 
generation of precursor metabolites and energy - 0.002098202 
regulation of cellular component biogenesis + 0.002415636 
organonitrogen compound metabolic process - 0.003771562 
single-organism biosynthetic process - 0.004152248 
establishment or maintenance of cell polarity + 0.004802956 
hematopoietic or lymphoid organ development + 0.005683962 
regulation of protein stability + 0.006389161 
maintenance of location in cell + 0.006389161 
regulation of RNA stability + 0.007549147 
stem cell maintenance + 0.008089919 
cellular response to abiotic stimulus + 0.008513448 
digestion - 0.008858864 
cellular macromolecule localization + 0.00887381 
xenobiotic metabolic process - 0.011159448 
positive regulation of molecular function + 0.011159448 
small molecule metabolic process - 0.012258654 
regulation of blood pressure - 0.013099716 
protein localization + 0.013474158 
nuclear import + 0.013741009 
immune response-regulating cell surface receptor 
signaling pathway involved in phagocytosis 
+ 0.013741009 
regulation of membrane potential - 0.013741009 
response to fibroblast growth factor stimulus + 0.015266984 
activation of innate immune response + 0.015346946 
extracellular structure organization - 0.018782087 
cell death + 0.031538537 
regulation of immune system process + 0.036331984 
cellular response to stimulus + 0.036331984 
endosomal transport + 0.038372379 
cerebral cortex development + 0.042836664 
regulation of localization + 0.045866007 
*p-value is corrected for multiple testing; plus sign represent enriched processes and minus sign 
represent depleted processes. 
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8.4 The top 50 genes with heritable transcriptional activity 
 
Table 8-4: The top 50 genes with heritable transcriptional activity; the best fit model for these 
genes was AE (A=additive genetic effect, E=unique environmental effect).  
Gene symbol Gene name Best fit 
model 
Heritability 
estimate 
MDGA1  MAM domain containing glycosylphosphatidylinositol anchor 1 AE 0.989 
FAM110C  family with sequence similarity 110, member C AE 0.980 
HLA-DRB5  major histocompatibility complex, class II, DR beta 5 AE 0.977 
HLA-DQB1  major histocompatibility complex, class II, DQ beta 1 AE 0.976 
FAM118A  family with sequence similarity 118, member A AE 0.971 
PPP1R17  protein phosphatase 1, regulatory subunit 17 AE 0.968 
HLA-DQA2  major histocompatibility complex, class II, DQ alpha 2 AE 0.968 
LOC338817  uncharacterized LOC338817  AE 0.964 
LOC253039  uncharacterized LOC253039 AE 0.960 
ZNF630  zinc finger protein 630 AE 0.958 
GAS1  growth arrest-specific 1 AE 0.956 
ERAP2  endoplasmic reticulum aminopeptidase 2 AE 0.951 
BEGAIN  brain-enriched guanylate kinase-associated AE 0.951 
LRRC37A2  leucine rich repeat containing 37, member A2 AE 0.950 
SNORA70  small nucleolar RNA, H/ACA box 70 AE 0.948 
LILRA3  leukocyte immunoglobulin-like receptor, subfamily A (without 
TM domain), member 3 
AE 0.948 
NNAT  neuronatin AE 0.948 
CHRNA7  cholinergic receptor, nicotinic, alpha 7 (neuronal) AE 0.947 
PAWR  PRKC, apoptosis, WT1, regulator AE 0.945 
ADAMTS8  ADAM metallopeptidase with thrombospondin type 1 motif, 8 AE 0.944 
GSTM1  glutathione S-transferase mu 1 AE 0.944 
MYCBPAP  MYCBP associated protein AE 0.944 
LOC100288778 WAS protein family homolog 1 pseudogene  AE 0.943 
LOC254099 uncharacterized LOC254099  AE 0.942 
CNTNAP2  contactin associated protein-like 2 AE 0.942 
SPATA20  spermatogenesis associated 20 AE 0.941 
CYP2B7P1  cytochrome P450, family 2, subfamily B, polypeptide 7 
pseudogene 1 
AE 0.940 
LOC650623  BEN domain containing 3 pseudogene AE 0.939 
USP32P1  ubiquitin specific peptidase 32 pseudogene 1 AE 0.939 
RGS17  regulator of G-protein signaling 17 AE 0.938 
HCG4  HLA complex group 4 (non-protein coding) AE 0.936 
TCL1B  T-cell leukemia/lymphoma 1B AE 0.936 
BTN3A2  butyrophilin, subfamily 3, member A2 AE 0.935 
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Gene symbol Gene name Best fit 
model 
Heritability 
estimate 
LOC654433 uncharacterized LOC654433  AE 0.934 
NIPAL4  NIPA-like domain containing 4 AE 0.934 
MTUS2  microtubule associated tumor suppressor candidate 2 AE 0.934 
TREML4  triggering receptor expressed on myeloid cells-like 4 AE 0.934 
APOBEC3B  apolipoprotein B mRNA editing enzyme, catalytic polypeptide-
like 3B 
AE 0.933 
DCLK2  doublecortin-like kinase 2 AE 0.932 
C17orf97  chromosome 17 open reading frame 97 AE 0.931 
TEKT4P2  tektin 4 pseudogene 2 AE 0.931 
KANSL1-AS1  KANSL1 antisense RNA 1 AE 0.931 
CCDC163P  coiled-coil domain containing 163, pseudogene AE 0.930 
SIGLEC14  sialic acid binding Ig-like lectin 14 AE 0.930 
LOC100134868  uncharacterized LOC100134868  AE 0.929 
PGM5  phosphoglucomutase 5 AE 0.927 
LOC283089  hypothetical LOC283089 AE 0.927 
DPYSL4  dihydropyrimidinase-like 4 AE 0.927 
COL9A3  collagen, type IX, alpha 3 AE 0.926 
LOC339666 uncharacterized LOC339666  AE 0.925 
 
8.5 GO terms identified in the validation dataset (the Danish sample) 
 
Table 8-5 All the significantly represented biological processes with respect to the genes 
upregulated and downregulated in LLI (in the validation dataset). 
Biological processes enriched/depleted p-value* 
With respect to the upregulated genes 
generation of precursor metabolites and energy + 0.000113 
cellular response to stress + 0.000113 
response to other organism + 0.000113 
oxidation-reduction process + 0.000113 
antigen processing and presentation of exogenous 
antigen 
+ 0.000523 
response to virus + 0.000691 
viral process + 0.000691 
symbiosis, encompassing mutualism through 
parasitism 
+ 0.000691 
antigen processing and presentation of peptide 
antigen 
+ 0.00082 
cell cycle process + 0.001366 
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Biological processes enriched/depleted p-value* 
regulation of multi-organism process + 0.001694 
regulation of body fluid levels - 0.007592 
defense response to virus + 0.008569 
hydrogen transport + 0.009093 
cell cycle + 0.034471 
coagulation - 0.037905 
embryonic morphogenesis - 0.037905 
chromosome segregation + 0.038531 
cytokine production + 0.041176 
organ development - 0.041176 
regulation of developmental process - 0.041415 
defense response + 0.041426 
system development - 0.041426 
cellular catabolic process + 0.041426 
With respect to the downregulated genes 
cellular macromolecule metabolic process + 5.64E-20 
regulation of metabolic process + 3.45E-17 
macromolecule metabolic process + 1.85E-16 
nucleobase-containing compound metabolic 
process 
+ 2.6E-13 
heterocycle metabolic process + 6.46E-12 
cellular aromatic compound metabolic process + 6.46E-12 
organic cyclic compound metabolic process + 5.77E-10 
regulation of cellular process + 1.94E-09 
cellular nitrogen compound metabolic process + 2.43E-09 
positive regulation of biological process + 1.23E-08 
organelle organization + 4.09E-08 
negative regulation of biological process + 2.12E-06 
RNA transport + 6.36E-06 
regulation of developmental process + 7.13E-05 
viral process + 8.59E-05 
symbiosis, encompassing mutualism through 
parasitism 
+ 8.59E-05 
modification of morphology or physiology of other 
organism involved in symbiotic interaction 
+ 9.08E-05 
modification of morphology or physiology of other 
organism 
+ 0.000191 
cellular response to chemical stimulus + 0.000349 
regulation of cellular component organization + 0.00045 
cellular biosynthetic process + 0.000535 
protein metabolic process + 0.000999 
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Biological processes enriched/depleted p-value* 
interaction with host + 0.001251 
regulation of response to stimulus + 0.001272 
organic substance biosynthetic process + 0.001303 
thymic T cell selection + 0.001566 
macromolecule methylation + 0.001688 
embryo development + 0.002603 
response to organic substance + 0.003583 
cellular response to endogenous stimulus + 0.004464 
nuclear import + 0.005275 
positive regulation of molecular function + 0.00533 
response to fibroblast growth factor stimulus + 0.007193 
cell cycle process + 0.007488 
gene silencing + 0.00777 
regulation of RNA stability + 0.008396 
regulation of immune system process + 0.010293 
somatic stem cell maintenance + 0.01146 
ribonucleoprotein complex biogenesis + 0.012142 
response to topologically incorrect protein + 0.012992 
carbohydrate transport + 0.014469 
regulation of signaling + 0.014469 
stem cell maintenance + 0.019812 
cellular component disassembly + 0.03276 
single-organism biosynthetic process - 0.033952 
nitrogen compound transport + 0.034536 
single-organism catabolic process - 0.036281 
cell cycle + 0.043801 
regulation of multicellular organismal process + 0.044714 
protein export from nucleus + 0.046254 
ribonucleoprotein complex localization + 0.048642 
*p-value is corrected for multiple testing; plus sign represent enriched processes and minus sign 
represent depleted processes. 
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8.6 RT-qPCR results 
 
Table 8-6 RT-qPCR results: The candidate genes that showed differential expression.  
Gene symbol TaqMan assay ID p-value* Fold change 
SATB1 Hs00161515_m1 4.73E-13 -2.42993 
PRKCA Hs00925193_m1 4.73E-13 -2.64929 
MAN1C1 Hs00220595_m1 1.10E-12 -2.79214 
ETS1 Hs00428293_m1 3.71E-12 -4.05408 
HIVEP2 Hs00198801_m1 4.39E-10 -3.69304 
SPTBN1 Hs00162271_m1 6.35E-10 -2.32152 
GZMH Hs00277212_m1 3.69E-09 4.008934 
ETV7 Hs00903229_m1 3.16E-08 3.099065 
ZNF551 Hs00292939_m1 1.07E-07 -2.3261 
DYNLT1 Hs00831821_s1 1.89E-07 1.468047 
RNASE3 Hs01923184_s1 3.05E-06 2.371746 
DDB2 Hs03044953_m1 3.05E-06 1.319008 
CAPG Hs00156249_m1 5.59E-06 1.419846 
AXIN2 Hs00610344_m1 1.22E-05 -3.13352 
BLVRA Hs00167599_m1 1.87E-05 1.438033 
LRRN3 Hs01087516_m1 1.87E-05 Ɨ 
C1QA Hs00706358_s1 2.09E-05 2.038951 
TSPYL5 Hs00603217_s1 3.53E-05 -2.28605 
MDK Hs00171064_m1 5.16E-05 2.266511 
TCN1 Hs01055542_m1 5.58E-05 1.568374 
HOXB7 Hs00270131_m1 5.99E-05 Ɨ 
CCL4 Hs00237011_m1 6.53E-05 1.657879 
CCL23 Hs00270756_m1 6.57E-05 3.97179 
ZNF154 Hs01068902_m1 1.05E-04 -2.30519 
ZNF135 Hs00987427_g1 2.08E-04 -3.38452 
IFNG Hs00989291_m1 0.000293 2.376178 
IGFBP2 Hs01040719_m1 4.46E-04 4.344896 
MARCO Hs00198935_m1 0.000682 2.547829 
ARG1 Hs00968979_m1 0.000854 1.641064 
NT5C3B Hs00369454_m1 0.001062 1.555315 
MMP23B Hs04187882_g1 0.00115 14.95619 
SEPT4 Hs00910208_g1 0.001276 1.308085 
CYB5R2 Hs00212055_m1 0.001652 1.281561 
LAP3 Hs00429769_m1 0.001889 1.391026 
SPHK1 Hs00184211_m1 0.002469 1.486209 
RAPGEF3 Hs00183449_m1 0.002517 Ɨ 
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Gene symbol TaqMan assay ID p-value* Fold change 
NUDT18 Hs00368715_m1 0.002907 2.217249 
PLA2G16 Hs00912734_m1 0.003144 1.331811 
PDGFRB Hs01019589_m1 0.004556 1.923654 
CTSL Hs00377632_m1 0.005949 1.319879 
HP Hs00605928_g1 0.011211 1.467194 
CTSK Hs00166156_m1 0.011289 1.180602 
NR1H3 Hs00172885_m1 0.01165 1.283037 
CXCL10 Hs01124251_g1 0.011791 1.39991 
APOL4 Hs00540930_m1 0.013613 1.072431 
ELANE Hs00975994_g1 0.017904 1.698913 
PRTN3 Hs01597752_m1 0.018185 1.640084 
CTSG Hs00175195_m1 0.029258 2.182746 
SERPINB10 Hs00192370_m1 0.034501 1.692342 
ELF3 Hs00963881_m1 0.045846 1.469627 
*p-value is corrected for multiple testing ;Ɨ the median expression level for these genes was zero 
either in LLI or in young individuals. Therefore, fold change could not be quantified for these 
genes.  
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9 Curriculum vitae 
 
Personal data  
Name Geetha Venkatesh 
Address Harmsstr. 62 
D-24114 Kiel 
Germany 
Date of birth 01.11.1984 
Place of birth Nagari, Andhra Pradesh, India 
Citizenship Indian 
Marital status Married 
  
Education  
1990 – 1994 The primary school, Bangalore, India 
1994 – 1997 The higher primary school, Bangalore, India 
1997 – 2000 The higher secondary school, Bangalore, India 
2000 – 2002 Pre-university course, Bangalore, India 
  
Study  
2002 – 2006 Bachelor of Engineering in Biotechnology at Acharya Institute of 
Technology, Bangalore, India  
2007 – 2010 Master of Science in Life Science Informatics at  
Bonn University, Bonn, Germany 
2010 – Today PhD work at the Institute of Clinical Molecular Biology, 
Christian-Albrechts University of Kiel, Germany 
  
Declaration                                             
121 
 
10 Declaration 
Declaration 
Apart from the advice of my supervisors, Dr. Robert Häsler and Prof. Dr. Almut Nebel, 
this thesis is completely the result of my own work. No part of it has been submitted to 
any other board for another qualification. 
 
Erklärung  
 
Hiermit erkläre ich, daß diese Dissertation, abgesehen von der Beratung durch meine 
akademischen Lehrer Dr. Robert Häsler und Prof. Dr. Almut Nebel, nach Inhalt und Form 
meine eigene Arbeit ist. Sie hat weder im Ganzen noch zum Teil an anderer Stelle im 
Rahmen eines Promotionsverfahrens vorgelegen. 
 
 
 
Kiel, …………………………….   ……………………………………………………. 
       (Geetha Venkatesh) 
  
Acknowledgement                                             
122 
 
11 Acknowledgement 
Undertaking this PhD has been a truly life-changing experience for me and it would not 
have been possible without the support and guidance that I received from many people. 
It gives me a great pleasure in expressing my gratitude to all those people who have 
supported me.  
To begin with, my greatest appreciation and gratitude goes to my adviser, Prof. Almut 
Nebel for her trust and support. Her advice on both research as well as on my career 
have been priceless. She made it possible for me to have many wonderful discussions, 
which often provided fuel for the next round I needed to complete this long journey. 
The help and guidance given by her from time to time shall carry me a long way in the 
journey of life on which I am about to embark.  
I would like to say a very big thank you to my supervisor, Dr. Robert Haesler, who is 
always calm, relaxed and cared so much about my work. He was very patient and was 
always providing clear explanations when I was lost, constantly driving me with energy 
when I was tired, and always, always giving me his time, in spite of anything else that 
was going on. He has a wonderful knack for knowing when to help and when to send me 
away to figure it out on my own.   
I would like to express my sincere thanks to Prof. Philip Rosenstiel for providing me 
valuable inputs when I embarked on this journey. I also thank Prof. Qihua Tan for 
generously sharing his time and knowledge in our collaborative work on twins. I would 
like to thank our collaborators, Prof. Lene Christiansen and Prof. Kaare Christensen 
(University of Southern Denmark, Odense) for all the valuable discussions.   
I would like to thank the PopGen Biobank for the recruitment of probands and sample 
collection. Many thanks to Dorina Oelsner for extracting RNA from the samples and also 
for her expert help with real-time gene expression studies. I would also like to thank 
Ilona Urbach for preparing the samples for genotyping, Tanja Wesse and Genotyping 
Acknowledgement                                             
123 
 
lab for carrying out genotyping. Also, I wish to thank Melanie Friskovec, Dr. Markus 
Schilhabel and all the members of sequencing lab for transcriptome sequencing.   
I wish to thank all my colleagues at the Institute of Clinical Molecular Biology who were 
very supportive during the course of my PhD thesis. A special thanks to Dr. Friederike 
Flachsbart for all the fruitful discussions and continuous support throughout this long 
journey. Many thanks to Dr. Matthias Barann who introduced me to the RNA-
sequencing analysis. Also, thank you to Frauke Degenhardt for helping me with proof 
reading of this thesis.  
The biggest thank you goes to all my friends without whom I would have never made it. 
Thank you for all the moral and emotional support, thoughts and ideas, joy and 
laughter. 
I wish to thank the authors, developers and maintainers of the open source and tools 
used in this work. I would like to appreciate all the researchers whose works I have 
used, initially in understanding my field of research and later for updates. 
Last but not least, I would like to thank my family for their love and encouragement. I 
would like to express my deepest gratitude to my mom and husband who stood by me 
and shared with me both the great and the difficult moments of life. Thank you so much 
for your love and care. 
This work was funded by the INTERREG 4A programme Syddanmark-Schlewig-K.E.R.N. 
financed by EU funds from the European Regional Development Fund. 
 
 
 
